Document:

Exhibit 10.1

 

INVESTORS’ RIGHTS AGREEMENT

 

THIS INVESTORS’ RIGHTS
AGREEMENT (this “Agreement”) made as of the [ ] day of [ ], by and among Selina Holding Company, UK Societas (the
 “Company”), and the Company’s Holders who have executed a signature page or Joinder Agreement (as defined
below) to this Agreement (the “Shareholders”). Capitalized terms used but not otherwise defined herein shall have the
meanings ascribed to them in the Business Combination Agreement (defined below).

 

WITNESSETH:

 

WHEREAS,
on December 2, 2021, BOA Acquisition Corp., a Delaware corporation (“BOA”), the Company, and Samba Merger
Sub, Inc., a Delaware corporation (“Merger Sub”), entered into that certain Business Combination Agreement
(as amended, supplemented or otherwise modified from time to time in accordance with its terms, the “Business Combination
Agreement”), pursuant to which, among other things, Merger Sub will merge with and into BOA, with BOA as the surviving
company in the merger and, as a result of such merger, among other things, all of the issued and outstanding capital stock of BOA at
the Effective Time shall be automatically converted into the right to receive Shares, in each case, on the terms and subject to the
conditions set forth in the Business Combination Agreement;

 

WHEREAS,
this Agreement is being executed concurrently with, and will become effective upon, the Closing (as defined below); and

 

WHEREAS,
the Shareholders and the Company desire to set forth certain matters regarding the ownership of the shares of the Company as set forth
below.

 

NOW,
THEREFORE, in consideration of the mutual promises and covenants set forth herein, the parties hereby agree as follows:

 

1.            Affirmative
Covenants.

 

1.1            Confidentiality.
Each Shareholder agrees that any information obtained pursuant to this Agreement (including any information about any proposed registration
or offering pursuant to Section 2 or Section 3) will not be disclosed or used for any purpose other than the exercise of rights
under this Agreement without the prior written consent of the Company; provided, that each Shareholder may disclose any such information
on a confidential basis to its directors, officers, employees and representatives.

 

2.             Registration.
The following provisions govern the registration of the Company’s securities:

 

2.1            Definitions.
As used herein, the following terms have the following meanings:

 

2.1.1       “BOA
Class A Shares” means the number of shares of BOA Class A Common Stock outstanding after giving effect to the BOA
Stockholder Redemption and the BOA Class B Conversion.

 

     

     

    

 

2.1.2        “BOA
Warrants” means the BOA Public Warrants held following the Unit Separation.

 

2.1.3        “Business
Day” means any day other than a Saturday, a Sunday or other day on which commercial banks in New York, New York are authorized
or required by applicable law to close.

 

2.1.4        “Closing”
means the closing of the Business Combination.

 

2.1.5        “Closing
Date” means the date of the Closing.

 

2.1.6        “Company
Executives” means members of the Company Board and any other Company executive officers at Closing.

 

2.1.7        “Company
Executive Lock-up Period” shall mean, with respect to the Company Executive Shares (x) the earlier of (a) one (1) year
from the Closing and (b) when the closing price of the Shares is equal to or greater than $12.00 for any twenty (20) trading days
within a thirty (30) trading day period (provided that if such condition is satisfied during the first six (6) months from the Closing
Date, such restriction on transfer will not lapse until the six (6) month anniversary of the Closing), or (y) in any case, if,
after the date hereof, the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in
all of the Company’s shareholders having the right to exchange their Shares for cash, securities or other property.

 

2.1.8        “Company
Executive Shares” means the Shares held by the Company Executives immediately following the Closing Date.

 

2.1.9        “Exchange
Act” means the Securities Exchange Act of 1934, as it may be amended from time to time.

 

2.1.10      “Form F-3”
means Form F-3 under the Securities Act, as in effect on the date hereof or any registration form under the Securities Act subsequently
adopted by the SEC which permits inclusion or incorporation of substantial information by reference to other documents filed by the Company
with the SEC after the date thereof or, if the Company is at any time not a foreign private issuer, Form S-3 under the Securities
Act as in effect on the date hereof or any registration form under the Securities Act subsequently adopted by the SEC which permits inclusion
or incorporation of substantial information by reference to other documents filed by the Company with the SEC.

 

2.1.11      “Holder”
means any Shareholder that is party to this Agreement and holds outstanding Registrable Securities.

 

2.1.12      “Holder
Lock-up Period” shall mean the Major Holder Lock-up Period or the Minor Holder Lock-up Period, as the case may be.

 

2.1.13      “Holder
Lock-up Shares” shall mean with respect to the Holders (other than the Company Executives and the Sponsor) and their respective
Permitted Transferees, the Shares held by such Holders prior to the Closing (excluding, for the avoidance of doubt, any Shares purchased
in a private placement in connection with the Business Combination or acquired in the public market following the Closing) and any Shares
issuable upon conversion or exercise of warrants, options or any other instrument held by the Holders as of immediately prior to the Closing.

 

    2

     

    

  

2.1.14     “immediate
family” shall mean any relationship by blood, marriage, domestic partnership or adoption, not more remote than first cousin.

 

2.1.15     “Initiating
Holders” means (a) the Major Shareholder Initiating Holders or (b) Sponsor.

 

2.1.16     “Joinder
Agreement” means a joinder agreement, in substantially the form attached hereto as Exhibit A.

 

2.1.17      “Major
Shareholder” means any Holder that (a) is listed on 0 attached hereto or (b) holds at least five percent (5%)
of the Company’s issued and outstanding share capital.

 

2.1.18     “Major
Shareholder Initiating Holders” means Major Shareholders holding more than ten percent (10%) of the then-outstanding Registrable
Securities.

 

2.1.19      “Major
Holder Lock-up Period” shall mean, in respect of those Holders and their permitted transferees (but excluding the Sponsor and
the Executives) who hold at Closing at least five percent (5%) of the Shares: (x) the earlier of (a) one (1) year from
the Closing and (b) when the closing price of the Shares is equal to or greater than $12.00 for any twenty (20) trading days within
a thirty (30) trading day period (provided that if such condition is satisfied during the first six (6) months from the Closing Date,
such restriction on transfer will not lapse until the six (6) month anniversary of the Closing), or (y) in any case, if, after
the date hereof, the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in all
of the Company’s shareholders having the right to exchange their Shares for cash, securities or other property; provided
that in the sole discretion of the majority of the independent members of the Board, the Majority Holder Lock-Up Period may end earlier
than as provided herein upon written notice to the Major Shareholders.

 

2.1.20      “Minor
Holder Lock-up Period” shall mean, in respect of those Holders and their permitted transferees (but excluding the Sponsor and
the Executives) who hold at Closing one percent (1%) or more but less than five percent (5%) of the Shares: (x) 180 days from the
Closing or (y) if earlier, the date on which the Company completes a liquidation, merger, capital stock exchange or other similar
transaction that results in all of the Company’s shareholders having the right to exchange their Shares for cash, securities or
other property; provided that in the sole discretion of the majority of the independent members of the Board, the Minor Holder
Lock-Up Period may end earlier than as provided herein upon written notice to Holders.

 

2.1.21      “Register”,
 “registered” and “registration” refer to a registration effected by filing a Registration Statement
in compliance with the Securities Act and the declaration or ordering by the SEC of effectiveness of such Registration Statement, or the
equivalent actions under the laws of another jurisdiction.

 

    3

     

    

 

2.1.22      “Registrable
Securities” means (i) the Sponsor Shares; (ii) the Sponsor Warrants; (iii) the Shares owned by any Holder party
hereto, including any Shares issuable upon the exercise of Continuing Options, and (iv) any other equity security of the Company
issued or issuable with respect to any such Shares by way of a stock dividend or stock split or in connection with a combination of stock,
acquisition, recapitalization, consolidation, reorganization, stock exchange, stock reconstruction and amalgamation or contractual control
arrangement with, purchasing all or substantially all of the assets of, or engagement in any other similar transaction; provided, further,
that Shares shall cease to be Registrable Securities on the later to occur of (x) as to any Holder that holds more than five
percent 5% of then outstanding Shares, two (2) years after the date of the Business Combination and (y) when they are freely
saleable without registration by the holder thereof pursuant to Rule 144 (without the need for any manner of sale requirement or
volume limitation and without the requirement for the Company to be in compliance with the current public information requirement under
Rule 144(c)(1) (or Rule 144(i)(2), if applicable)) or sold pursuant to Rule 144 or a Registration Statement.

  

2.1.23      “Registration
Statement” shall mean any registration statement that covers Registrable Securities pursuant to the provisions of this Agreement,
including the prospectus included in such registration statement, amendments (including post-effective amendments) and supplements to
such registration statement, and all exhibits to and all material incorporated by reference in such registration statement.

 

2.1.24      “SEC”
means the Securities and Exchange Commission.

 

2.1.25      “Securities
Act” means the Securities Act of 1933, as amended.

 

2.1.26      “Shares”
means, following the Closing Date, the Company Ordinary Shares.

 

2.1.27      “Shelf
Registration” shall mean a registration of securities pursuant to a Registration Statement filed with the SEC in accordance
with and pursuant to Rule 415 promulgated under the Securities Act (or any successor rule then in effect)

 

2.1.28      “Sponsor”
shall mean Bet on America LLC, a Delaware Limited Liability Company.

 

2.1.29      “Sponsor
Lock-up Period” shall mean, with respect to the Sponsor Shares and Sponsor Warrants held by the Sponsor, the earlier of (a) one
(1) year from the Closing and (b) when the closing price of the Shares is equal to or greater than $12.00 for any twenty (20)
trading days within a thirty (30)-trading day period (provided that if such condition is satisfied during the first six months from the
Closing Date, such restriction on transfer will not lapse until the six-month anniversary of the Closing), or (y) in any case, if,
after the date hereof, the Company completes a liquidation, merger, capital stock exchange or other similar transaction that results in
all of the Company’s shareholders having the right to exchange their Shares for cash, securities or other property; provided
that in the sole discretion of the majority of the independent members of the Board, the Sponsor Lock-Up Period may end earlier than as
provided herein upon written notice to the Sponsor.

 

    4

     

    

 

2.1.30     “Sponsor
Shares” means Shares issued to the Sponsor on account of the BOA Class A Shares and the exercise by the Company of the
BOA Warrants at the Closing.

  

2.1.31      “Sponsor
Warrants” means the private placement warrants held by the Sponsor at the Effective Time and subject to vesting upon the satisfaction
of certain agreed post-Closing milestones.

 

2.1.32     “Transaction
Documents” means this Agreement, the schedules and exhibits attached hereto, the Irrevocable Transfer Agent Instructions and
any other documents or agreements explicitly contemplated hereunder.

 

2.1.33      “Transfer”
shall mean, directly or indirectly, the (x) sale or assignment of, offer to sell, contract or agreement to sell, hypothecate, pledge,
grant of any option to purchase or otherwise dispose of or agreement to dispose of or establishment or increase of a put equivalent position
or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange Act with
respect to, any security, (y) entry into any swap or other arrangement that transfers to another, in whole or in part, any of the
economic consequences of ownership of, or any other derivative transaction with respect to, any security, whether any such transaction
is to be settled by delivery of such securities, in cash or otherwise, or (x) public announcement of any intention to effect any
transaction specified in clause (x) or (y).

 

2.2            Piggy-back
Registration. If the Company at any time beginning upon (but excluding) the Closing Date proposes to register any of its Shares (other
than (w) a shelf registration to register Shares issued to investors in a private placement in connection with the BOA Acquisition
Proposal, (x) a demand registration under Section 2.2, Section 2.5
or Section 2.5 of this Agreement, (y) in connection with a registration on Form S-8 or (z) pursuant to Form F-4
or S-4 in connection with a business combination or exchange offer or pursuant to exercise or conversion of outstanding securities) or
to undertake an underwritten public offering of its securities pursuant to an effective Registration Statement (a “Shelf Takedown”)
it shall give written notice to all Holders of such intention not less than ten (10) days before the anticipated filing date of
the applicable Registration Statement, which notice shall (A) describe the amount and type of securities to be included in such
offering, the intended method(s) of distribution, and the name of the proposed managing underwriter or underwriters, if any, in
such offering, and (B) offer to all of the Holders the opportunity to register the sale of such number of Registrable Securities
of the same type as are included in the Registration Statement as such Holders may request in writing. Upon the written request of any
Holder given within seven (7) days after receipt of any such notice, the Company shall include in such registration or Shelf Takedown
all of the Registrable Securities indicated in such request, so as to permit the disposition of the shares so registered; provided
that no Holder who is subject to a lockup with respect to such Holder’s Registrable Securities shall have any right to have
such Registrable Securities participate in such registration or offering except to the extent such lockup has expired or been waived.
The Company shall, in good faith, cause such Registrable Securities to be included in such registration or offering and, if applicable,
shall use its commercially reasonable efforts to cause the managing underwriter(s) of such registration to permit the Registrable
Securities requested by the Holders pursuant to this Section 2.2 to be included therein on the same terms and conditions as any
similar securities of the Company included in such registered offering and to permit the sale or other disposition of such Registrable
Securities in accordance with the intended method(s) of distribution thereof. Notwithstanding any other provision of this Section 2.2,
if the managing underwriter advises the Company in writing that marketing factors require a limitation of the number of shares to be
underwritten, then shares will be included in such registration or Shelf Takedown up to such limitation in the following order or priority:
(i) first, all Shares that were being registered by the Company or pursuant to the exercise of demand rights by holders not party
to this Agreement, (ii) second, all Registrable Securities held by the Holders must be included in such registration (pro rata to
the respective number of Registrable Securities held by the Holders) and (iii) third, any other shares of the Company to be offered
by any other holders will be included in such registration. The piggyback rights of the Holders under this Section may be exercised
an unlimited number of times. Any Holder may elect to withdraw such Holder’s request for inclusion of Registrable Securities in
any Registration Statement pursuant to this Section 2.2 by giving written notice to the Company of such request to withdraw prior
to the effectiveness of the Registration Statement. The Company (whether on its own determination or as the result of a withdrawal by
persons making a demand pursuant to written contractual obligations) may withdraw a Registration Statement at any time prior to the effectiveness
of such Registration Statement.

 

    5

     

    

  

2.3            Demand
Registration. At any time following the Closing and expiration or waiver of any lockup applicable
to such Holders party hereto, the Initiating Holders may request in writing that all or part of the Registrable Securities held by them
shall be registered under the Securities Act (a “Demand Registration”). Within ten (10) days after receipt of
any such request, the Company shall give written notice of such request to the other Holders and shall include in such registration all
Registrable Securities held by all such Holders who wish to participate in such demand registration and provide the Company with written
requests for inclusion therein within seven (7) days after the receipt of the Company’s notice; provided that no Holder
who is subject to a lockup with respect to such Holder’s Registrable Securities shall have any right to have such Registrable Securities
participate in such registration or offering except to the extent such lockup has expired or been waived. Thereupon, the Company shall
effect the registration of all Registrable Securities as to which it has received requests for registration as soon as practicable; provided
that (i) the Company shall not be required to effect any registration under this Section 2.2
(x) within a period of ninety (90) days following the effective date of a previous registration and (y) with respect to Registrable
Securities with a total offering price not reasonably expected to exceed, in the aggregate, $50 million, and (ii) this provision
shall not apply if a shelf registration on Form F-3 has been filed pursuant to Section 2.5 and is effective and available for
use. The Company shall not be required to effect more than (A) two (2) registration under this Section 2.3 requested by
the Sponsor and (B) three (3) registrations under this Section 2.2
requested by the Major Shareholder Initiating Holders. If the Company shall furnish to the Holders a certificate signed by the Chief Executive
Officer of the Company stating that in the good faith judgment of the Company Board it would be seriously detrimental to the Company or
its shareholders for a registration under this Section 2.2 to be
effected at such time, the Company shall have the right to defer such registration for a period of not more than ninety (90) days after
receipt of the request of the Initiating Holders under this Section 2.2,
provided that the Company shall not utilize this right more than once in any twelve (12) month period. The Initiating Holders may
elect to withdraw from any offering pursuant to this Section 2.3 by giving written notice to the Company and the underwriter(s) of
their request to withdraw prior to the effectiveness of the Registration Statement filed with the SEC with respect to such Demand Registration.
If the Initiating Holders withdraw from a proposed offering relating to a Demand Registration then either the Initiating Holders shall
reimburse the Company for the costs associated with the withdrawn Demand Registration (in which case such registration shall not count
as a Demand Registration provided for in this Section 2.3) or such withdrawn registration shall count as a Demand Registration provided
for in this Section 2.3.

 

    6

     

    

 

Notwithstanding
any other provision of this Section 2.2, if the managing underwriter advises the Holders in writing that marketing factors
require a limitation on the dollar amount or the number of shares to be underwritten, then the amount of Registrable Securities proposed
to be registered shall be reduced pro rata to the respective number of Registrable Securities held by the Holders; provided that
in any event all Registrable Securities held by the Initiating Holders and any other Holders that elect to participate in any such registration
must be included in such registration (pro rata based on the total amount of Registrable Securities held by each such Initiating Holder
or other Holder, as applicable) prior to any other shares of the Company, including shares held by persons other than Holders. The Company
shall not register securities for sale for its own account in any registration requested pursuant to this Section 2.2
unless permitted to do so by the written consent of the Initiating Holders.

 

2.4            F-1
Registration Statement. If the SEC publicly announces or informs the Company that Rule 144(i) applies to the Company or
the Company determines that it is reasonably likely that Rule 144(i) applies to the Company, the following provision shall apply.
The Company shall, as soon as practicable after such notice from the SEC or such determination that Rule 144(i) is reasonably
likely to apply to the Company, but in any event within thirty (30) days thereafter, file a Registration Statement under the Securities
Act to permit the public resale of all the Registrable Securities held by any Holder from time to time as permitted by Rule 415 under
the Securities Act (or any successor or similar provision adopted by the SEC then in effect) on the terms and conditions specified in
this Section 2.4 and shall use its reasonable commercial efforts to cause such Registration Statement to be declared effective as
expeditiously as possible after the filing thereof. The Registration Statement filed with the SEC pursuant to this Section 2.4 shall
be on Form F-1, with respect to such Registrable Securities (the “Shelf”),
and shall contain a prospectus in such form as to permit (subject to the Lock-up) the Holders to sell such Registrable Securities pursuant
to Rule 415 under the Securities Act (or any successor or similar provision adopted by the SEC then in effect), or such other means
of distribution of Registrable Securities as the Holders may reasonably specify, at any time beginning on the effective date for such
Registration Statement; provided that the Company shall not be obligated to effect any such
registration, qualification, compliance or offering, pursuant to this Section 2.4, if (i) the Company shall furnish to the Holders
a certificate signed by the Chief Executive Officer of the Company stating that in the good faith judgment of the Company Board it would
be seriously detrimental to the Company or its shareholders for such Form F-1 registration statement or any Shelf Takedown pursuant
thereto to be effected at such time, in which event the Company shall have the right to defer the filing of the Form F-1 registration
statement for a period of not more than ninety (90) days; provided that the Company shall not utilize this right more than once
in any twelve (12) month period or (ii) during the period starting with the date sixty (60) days prior to the Company’s estimated
date of filing of, and ending on the date six (6) months immediately following the effective date of, any registration statement
pertaining to securities of the Company (other than a registration of securities in a Rule 145 transaction or with respect to an
employee benefit plan), provided that the Company is actively employing good faith reasonable efforts to cause such registration
statement to become effective and that the Company’s estimate of the date of filing such registration statement is made in good
faith. The Company shall maintain the Shelf in accordance with the terms hereof, and shall prepare and file with the SEC such amendments,
including post-effective amendments, and supplements as may be necessary to keep such Shelf continuously effective, available for use
and in compliance with the provisions of the Securities Act until such time as there are no longer any Registrable Securities included
on such registration statement. The Company shall use its commercially reasonable efforts to convert the Form F-1 to a Form F-3
as soon as practicable after the Company is eligible to use Form F-3. A Registration Statement filed pursuant to this Section 2.4
shall provide for the resale pursuant to any method or combination of methods legally available to, and requested by, any Holder. Subject
to the second succeeding sentence, as soon as practicable following the effective date of a Registration Statement filed pursuant to this
Section 2.4, but in any event within three (3) Business Days of such date, the Company shall notify the Holders of the effectiveness
of such Registration Statement. The Holders may use such Form F-1 to dispose of their Registrable
Securities on a non-underwritten basis, and may utilize such Form F-1 on an underwritten basis if requested by Initiating Holders
(with any such request being deemed to be a demand pursuant to Section 2.2 and subject to the limits and rules set forth therein,
mutatis mutandis). If requested by any Holder, the Company shall promptly file with the SEC such post-effective amendments or supplements
to any such Form F-1 as may be necessary to name such Holder therein as a selling shareholder and otherwise permit such Holder to
sell Registrable Securities thereunder. References to Form F-1 herein (or any “long-form” successor thereto) shall
include references to Form S-1 (or any “long-form” successor thereto) if the Company ceases to be eligible to use Form F-1.

 

    7

     

    

 

2.5            Form F-3
Registration. In the event that the Company shall receive from any Major Shareholder or the Sponsor a written request or requests
that the Company effect a shelf registration on Form F-3 with respect to Registrable Securities (if no Form F-3 is then on file
and available for use by the Holders), the Company will within ten (10) days after receipt of any such request give written notice
of the proposed registration to all other Holders, and include in such registration all Registrable Securities held by all such Holders
who wish to participate in such registration and provide the Company with written requests for inclusion therein within seven (7) days
after the receipt of the Company’s notice; provided that no Holder who is subject to
a lockup with respect to such Holder’s Registrable Securities shall have any right to have such Registrable Securities participate
in such registration or offering except to the extent such lockup has expired or been waived. Thereupon,
the Company shall effect such registration and all such qualifications and compliances as may be reasonably so requested and as would
permit or facilitate the sale and distribution of all or such portion of such Holder’s or Major Shareholder’s Registrable
Securities as are specified in such request, together with all or such portion of the Registrable Securities of any other Holder joining
in such request as are specified in a written request given within seven (7) days after receipt of such written notice from the Company;
provided that the Company shall not be obligated to effect any such registration, qualification, compliance or offering, pursuant
to this Section 2.5, (i) if Form F-3 is not available for such registration or offering; (ii) if the Company shall
furnish to the requesting Major Shareholder a certificate signed by the Chief Executive Officer of the Company stating that in the good
faith judgment of the Company Board it would be seriously detrimental to the Company or its shareholders for such Form F-3 registration
statement or Shelf Takedown pursuant thereto to be effected at such time, in which event the Company shall have the right to defer the
filing of the Form F-3 registration statement or Shelf Takedown for a period of not more than ninety (90) days after receipt of the
request of the Major Shareholder under this Section 2.5; provided that the Company shall not utilize this right more than
once in any twelve (12) month period; or (iii) during the period starting with the date sixty (60) days prior to the Company’s
estimated date of filing of, and ending on the date six (6) months immediately following the effective date of, any registration
statement pertaining to securities of the Company (other than a registration of securities in a Rule 145 transaction or with respect
to an employee benefit plan), provided that the Company is actively employing good faith reasonable efforts to cause such registration
statement to become effective and that the Company’s estimate of the date of filing such registration statement is made in good
faith. The Holders may use such Form F-3 to dispose of their Registrable Securities on a non-underwritten basis, and may utilize
such Form F-3 on an underwritten basis if requested by Initiating Holders (with any such request being deemed to be a demand pursuant
to Section 2.2 and subject to the limits and rules set forth therein, mutatis mutandis). If requested by any Holder or Major
Shareholder, the Company shall promptly file with the SEC such post-effective amendments or supplements to any such Form F-3 as may
be necessary to name such Holder or Major Shareholder therein as a selling shareholder and otherwise permit such Holder or Major Shareholder
to sell Registrable Securities thereunder. References to Form F-3 herein (or any “short-form” successor thereto)
shall include references to Form S-3 (or any “short-form” successor thereto) if the Company ceases to be eligible to
use Form F-3.

 

    8

     

    

  

2.6            Designation
of Underwriter. In the case of any registration effected pursuant to Section 2.2, the Company shall have the right to designate
the managing underwriters in any underwritten offering, subject to the prior written approval of the Major Shareholders that hold a majority
of the Registrable Securities held by the Initiating Holders, in each case, which shall not be unreasonably withheld, conditioned or delayed.
In the case of any registration initiated by the Company, the Company shall have the right to designate the managing underwriter in any
underwritten offering.

 

2.7            Expenses.
All expenses, including the reasonable fees and expenses of one counsel for the Initiating Holders in connection with any registration
under Section 2.2, Section 2.2, Section 2.5 or Section 2.5 and one counsel for the Sponsor in connection with any
registration under Section 3 shall be borne by the Company; provided that each of the Holders participating in such registration
shall pay its pro rata portion of discounts or commissions payable to any underwriter.

 

2.8            Indemnities.
In the event of any registered offering of Registrable Securities pursuant to this Section 2 or Section 3:

 

2.8.1        The
Company will indemnify and hold harmless, to the fullest extent permitted by law, each Holder, any underwriter of such Holder, each person,
if any, who controls the Holder or such underwriter and each of the foregoing person’s respective officers, directors, employees,
partners, members, attorneys, advisors, agents or other representatives (a “Holder Indemnified Party”), from and against
any and all losses, damages, claims, liabilities, joint or several, costs and expenses (including any amounts paid in any settlement effected
with the Company’s consent) to which any such Holder Indemnified Party may become subject under applicable law or otherwise, insofar
as such losses, damages, claims, liabilities (or actions or proceedings in respect thereof), costs or expenses arise out of or are based
upon (i) any untrue statement or alleged untrue statement of any material fact contained in the Registration Statement or included
in the prospectus, as amended or supplemented (ii) the omission or alleged omission to state therein a material fact required to
be stated therein or necessary to make the statements therein, in the light of the circumstances in which they are made, not misleading
and the Company will reimburse such Holder Indemnified Party promptly upon demand, for any reasonable documented, out-of-pocket legal
or any other expenses incurred by them in connection with investigating, preparing to defend or defending against or appearing as a third-party
witness in connection with such loss, claim, damage, liability, action or proceeding or (iii) any violation of alleged violation
by the Company of the Securities Act, the Exchange Act or any state securities law or any rule or regulation thereunder, in connection
with the performance of its obligations under this Agreement; provided that the Company will not be liable to any Holder Indemnified
Party in any such case to the extent that any such loss, damage, liability, cost or expense arises out of or is based upon an untrue statement
or alleged untrue statement or omission or alleged omission so made in conformity with information furnished by such Holder Indemnified
Party claiming for indemnification in writing specifically for inclusion therein; provided, further, that the indemnity agreement
contained in this subsection 2.8.1 shall not apply to amounts paid in settlement of any such claim, loss, damage, liability or action
if such settlement is effected without the consent of the Company, which consent shall not be unreasonably withheld, conditioned or delayed.
Such indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Holder Indemnified Party
and regardless of any sale in connection with such offering by the Holder Indemnified Party. Such indemnity shall survive the transfer
of securities by a selling shareholder.

 

    9

     

    

 

2.8.2        Each
Holder participating in a registration hereunder will furnish to the Company in writing any information regarding such Holder and his
or her intended method of distribution of Registrable Securities as the Company may reasonably request and will indemnify and hold harmless
the Company, any underwriter for the Company, any other person participating in the distribution, each person, if any, who controls the
Company, such underwriter or such other person and each of the foregoing person’s respective officers, directors, employees, partners,
members, attorneys, advisors, agents or other representatives (a “Company Indemnified Party”) from and against any
and all losses, damages, claims, liabilities, costs or expenses (including any amounts paid in any settlement effected with the selling
shareholder’s consent) to which any such Company Indemnified Party may become subject under applicable law or otherwise, insofar
as such losses, damages, claims, liabilities (or actions or proceedings in respect thereof), costs or expenses arise out of or are based
on (i) any untrue or alleged untrue statement of any material fact contained in the Registration Statement or included in the prospectus,
as amended or supplemented, or (ii) the omission or the alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein, in the light of the circumstances in which they were made, not misleading, but,
in each case, only to the extent of such information relating to such Holder and provided in writing by such Holder, and each such Holder
will reimburse such Company Indemnified Party promptly upon demand, for any reasonable legal or other expenses incurred by them in connection
with investigating, preparing to defend or defending against or appearing as a third-party witness in connection with such loss, claim,
damage, liability, action or proceeding; in each case to the extent, but only to the extent, that such untrue statement or alleged untrue
statement or omission or alleged omission was so made in strict conformity with written information furnished by such Holder specifically
for inclusion therein. The foregoing indemnity agreement shall be individual and several by each Holder. The indemnity agreement contained
in this subsection 2.8.2 shall not apply to amounts paid in settlement of any such claim, loss, damage, liability or action if such settlement
is effected without the consent of the Holders, as the case may be, which consent shall not be unreasonably withheld, conditioned or
delayed. In no event shall the liability of a Holder exceed the net proceeds from the offering received by such Holder.

 

    10

     

    

 

2.8.3        Promptly
after receipt by an indemnified party pursuant to the provisions of Sections 2.8.1 or 2.8.2 of notice of the commencement of any action
involving the subject matter of the foregoing indemnity provisions, such indemnified party will, if a claim thereof is to be made against
the indemnifying party pursuant to the provisions of said Section 2.8.1 or 2.8.2, promptly notify the indemnifying party of the commencement
thereof; but the omission to notify the indemnifying party will not relieve it from any liability which it may have to any indemnified
party otherwise than hereunder. In case such action is brought against any indemnified party and it notifies the indemnifying party of
the commencement thereof, the indemnifying party shall have the right to participate in, and, to the extent that it may wish, jointly
with any other indemnifying party similarly notified, to assume the defense thereof with counsel reasonably satisfactory to such indemnified
party; provided that if the defendants in any action include both the indemnified party and the indemnifying party and the indemnified
party reasonably believes that there is a conflict of interests which would prevent counsel for the indemnifying party from also representing
the indemnified party, the indemnified party or parties shall have the right to select one separate counsel to participate in the defense
of such action on behalf of such indemnified party or parties. After notice from the indemnifying party to such indemnified party of its
election so to assume the defense thereof, the indemnifying party will not be liable to such indemnified party pursuant to the provisions
of said Sections 2.8.1 or 2.8.2 for any legal or other expense subsequently incurred by such indemnified party in connection with the
defense thereof, unless (i) the indemnified party shall have employed counsel in accordance with the provision of the preceding sentence,
(ii) the indemnifying party shall not have employed counsel reasonably satisfactory to the indemnified party to represent the indemnified
party within a reasonable time after the notice of the commencement of the action and within fifteen (15) days after written notice of
the indemnified party’s intention to employ separate counsel pursuant to the previous sentence, or (iii) the indemnifying party
has authorized the employment of counsel for the indemnified party at the expense of the indemnifying party. No indemnifying party will
consent to entry of any judgment or enter into any settlement if such settlement or judgment requires an admission of fault or culpability
on the part of the indemnified party or does not include as an unconditional term thereof the giving by the claimant or plaintiff to such
indemnified party of a release from all liability in respect to such claim or litigation.

 

    11

     

    

 

2.8.4        If
recovery is not available under the foregoing indemnification provisions, for any reason other than as specified therein, the parties
entitled to indemnification by the terms thereof shall be entitled to contribution to liabilities and expenses in such proportion as is
appropriate to reflect the relative fault of each of the indemnifying party and the indemnified party in connection with the statements,
omissions, or other actions that resulted in such loss, claim, damage, liability, or expense, as well as to reflect any other relevant
equitable considerations. In determining the amount of contribution to which the respective parties are entitled, there shall be considered
the parties’ relative knowledge and access to information concerning the matter with respect to which the claim was asserted, the
opportunity to correct and prevent any statement or omission, and any other equitable considerations appropriate under the circumstances.
In no event shall the liability of a Holder exceed the net proceeds from the offering received by such Holder.

 

2.8.5        Notwithstanding
anything to the contrary hereunder, no person or entity guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
the Securities Act) shall be entitled to contribution pursuant to this Section 2.8 from any person or entity who was not guilty of
such fraudulent misrepresentation.

 

2.9           Obligations
of the Company. Whenever required under this Section 2 to effect the registration of any Registrable Securities, the Company
shall, as expeditiously as possible:

 

2.9.1        prepare
and file with the SEC a Registration Statement with respect to such Registrable Securities and use its reasonable commercial efforts to
cause such Registration Statement to become effective, and, upon the request of the holders of a majority of the Registrable Securities
registered thereunder, keep such Registration Statement effective for a period of up to twelve (12) months or, if sooner, until the distribution
contemplated in the Registration Statement has been completed, and, in the case of any registration of Registrable Securities on Form F-3
that are intended to be offered on a continuous or delayed basis, subject to compliance with applicable SEC rules, such twelve (12) month
period shall be extended for up to three (3) years, if necessary, to keep the Registration Statement effective until all such Registrable
Securities are sold.

 

2.9.2        subject
to the suspension rights set forth in Section 2.2 and 2.5, prepare and file with the SEC such amendments and supplements to such
Registration Statement and the prospectus used in connection with such Registration Statement as may be necessary to comply with the provisions
of the Securities Act with respect to the disposition of all Registrable Securities covered by such Registration Statement.

 

2.9.3        use
commercially reasonable efforts to furnish to the Holders such numbers of copies of a prospectus, including a preliminary prospectus,
and any amendments or supplements to such a prospectus, without charge to the holders of Registrable Securities included in such registration
and in conformity with the requirements of the Securities Act, and such other documents as they may reasonably request in order to facilitate
the disposition of Registrable Securities owned by them.

 

2.9.4         in
the event of any underwritten public offering, enter into and perform its obligations under an underwriting agreement, in usual and customary
form, with the managing underwriter of such offering. Each Holder participating in such underwriting shall also enter into and perform
its obligations under such an agreement.

 

    12

     

    

 

2.9.5         notify
each holder of Registrable Securities covered by such Registration Statement as promptly as reasonably practicable, but in any event within
three (3) Business Days, of: (i) such Registration Statement becoming effective; (ii) such time as any post-effective amendment
to such Registration Statement becomes effective; (iii) the issuance or threatened issuance by the SEC of any stop order; and (iv) any
request by the SEC for any amendment or supplement to such Registration Statement or any prospectus relating thereto or for additional
information or of the happening of any event as a result of which the prospectus included in such Registration Statement, as then in effect,
includes an untrue statement of a material fact or omits to state a material fact required to be stated therein or necessary to make the
statements therein not misleading in the light of the circumstances then existing.

  

2.9.6        cause
all Registrable Securities registered pursuant to this Section 2 to be listed on each securities exchange on which Shares
are then listed.

 

2.9.7        provide
a transfer agent and registrar for all Registrable Securities registered pursuant hereunder and a CUSIP number for all such Registrable
Securities, in each case not later than the effective date of such registration.

 

2.9.8         furnish,
at the request of any Holder requesting registration of Registrable Securities pursuant to this Section 2 at such Holder’s
expense, on the date that such Registrable Securities are delivered to the underwriters for sale in connection with a registration pursuant
to Section 2.2 or Section 2.2, if such securities are being sold through underwriters, (i) an opinion, dated such date,
of the counsel representing the Company for the purposes of such registration, in form and substance as is customarily given to underwriters
in an underwritten public offering, addressed to the underwriters, if any, and to the Holders requesting registration of Registrable Securities
and (ii) a letter dated such date, from the independent certified public accountants of the Company, in form and substance as is
customarily given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters,
if any, and to the Holders requesting registration of Registrable Securities.

 

2.9.9        in
the case of an underwritten offering involving gross proceeds in excess of $50 million, use its reasonable efforts to make available senior
executives of the Company to participate in customary “road show” presentations that may be reasonably requested by the underwriter.

 

2.9.10      the
Company shall enter into customary agreements and take such other actions as are reasonably required in order to expedite or facilitate
the disposition of such Registrable Securities.

 

2.10         Obligations
of the Holders. Without limiting the foregoing, no Holder may participate in any underwritten offering hereunder unless such Holder
(a) agrees to sell such Holder’s Registrable Securities on the basis provided in any underwriting arrangements approved by
the Company (in the case of a piggyback offering) or the Initiating Holders (in the case of a demand registration offering) and (b) completes
and executes all questionnaires, powers of attorney, indemnities, underwriting agreements and other documents reasonably required under
the terms of such underwriting arrangements and the provisions of this Agreement in respect of registration rights.

 

    13

     

    

 

2.11         Assignment
of Registration Rights. Other than as set forth in Section 2.12 or Section 4, any of the Major Shareholders may assign and/or
transfer its rights, wholly or partially, to cause the Company to register Shares pursuant to this Section 2 to a transferee of all
or any part of its Registrable Securities. In addition, any Holder may transfer and/or assign his right, wholly or partially, to transferees
of Shares that are Registrable Securities of the Company. The transferor shall, within twenty (20) days after such transfer, furnish the
Company with written notice of the name and address of such transferee and the securities with respect to which such registration rights
are being assigned, and the transferee shall execute a Joinder Agreement as required by Section 5.4 below.

 

2.12         Market
Stand-off. All Holders participating in an underwritten offering of Registrable Securities pursuant to this Agreement agree that any
Registrable Securities owned by them may be subject to a customary “lock-up” restricting sales, pledges or other dispositions
for up to ninety (90) days from the date of the final prospectus used in connection with any underwritten offering pursuant to Section 2
above by the Company in which the Company complied with Section 2.2, and each such Holder hereby makes, constitutes and appoints
the Company and each of its officers, acting alone, with full power of substitution and resubstitution, its true and lawful attorney,
for it and in its name, place and stead and for its use and benefit, to enter into and execute customary “lock-up” agreements
with respect to all Shares or securities convertible into, or exercisable for, Shares (with such officers being empowered to determine
the customary nature of such lockup), as applicable, (held immediately prior to the launch of such offering) and such Holder shall thereby
be required to abide by such “lock-up” period of up to ninety (90) days as is required by the managing underwriter(s) in
such registration; provided that such obligation shall only apply where all officers and directors are similarly bound. The foregoing
provisions of this Section 2.1.12 shall not apply to the sale of any shares to an underwriter pursuant to an underwriting agreement
in connection with such offering or any shares of the Company acquired in such offering or acquired in open market transactions after
such offering.

 

2.13         Public
Information. The Company shall make publicly available such information as is necessary to enable the Holders to make sales of Registrable
Securities pursuant to Rule 144 to the extent such rule is available to Holders at such time. Without limiting the foregoing,
in order to enable the Shareholders to sell the Shares under Rule 144, the Company shall use its commercially reasonable efforts
to timely file (or obtain extensions in respect thereof and file within the applicable grace period) all reports required to be filed
by the Company after the date hereof pursuant to the Exchange Act.

 

2.14         Form F-3
Eligibility. The Company shall, after becoming eligible to use Form F-3, use its reasonable best efforts to remain so eligible
(it being understood that the Company will not be required to issue additional capital stock to maintain a minimum public float).

 

2.15         Removal
of Legends. Upon Rule 144 becoming available for the resale of any Registrable Securities, without the requirement for the Company
to be in compliance with the current public information required under Rule 144 as to such securities and without volume or manner-of-sale
restrictions and expiration of any lock-up agreement applicable to such Shares, the Company shall promptly cause Company counsel to issue
to a transfer agent the legal opinion referred to in the Irrevocable Transfer Agent Instructions. Any fees (with respect to the transfer
agent, Company counsel or otherwise) associated with the issuance of such opinion or the removal of such legend shall be borne by the
Company. At such time, the Company will no later than five (5) trading days (such fifth (5th) trading day, the “Legend
Removal Date”) deliver or cause to be delivered to such Shareholder a certificate representing such Shares that is free from
all restrictive and other legends. Certificates for Shares subject to legend removal hereunder may be transmitted by a transfer agent
to the Shareholders by crediting the account of the Shareholder’s prime broker with Depository Trust Company as directed by such
Shareholder.

 

    14

     

    

 

2.15.1      Irrevocable
Transfer Agent Instructions. Following completion of the BOA Acquisition Proposal, the Company shall issue irrevocable instructions
to its transfer agent, and any subsequent transfer agent, in substantially the form of Exhibit B attached hereto (the “Irrevocable
Transfer Agent Instructions”). The Company represents and warrants that no instruction other than the Irrevocable Transfer Agent
Instructions referred to in this subsection 2.15.1 (or instructions that are consistent therewith) and instructions related to the lock-up
agreement contained herein will be given by the Company to its transfer agent in connection with this Agreement, and that the Shares shall
otherwise be freely transferable on the books and records of the Company as and to the extent provided in this Agreement and the other
Transaction Documents and applicable law. The Company acknowledges that a breach by it of its obligations under this subsection 2.15.1
will cause irreparable harm to a Shareholder. Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations
under this subsection 2.15.1 will be inadequate and agrees, in the event of a breach or threatened breach by the Company of the provisions
of this subsection 2.15.1, that a Shareholder shall be entitled, in addition to all other available remedies, to an order and/or injunction
restraining any breach and requiring immediate issuance and transfer, without the necessity of showing economic loss and without any bond
or other security being required.

 

2.15.2      Acknowledgement.
Each Shareholder hereunder acknowledges its primary responsibilities under the Securities Act and accordingly will not sell or otherwise
transfer the Shares or any interest therein without complying with the requirements of the Securities Act. Both the Company and its transfer
agent, and their respective directors, officers, employees and agents, may rely on this subsection 2.15.2 and each Shareholder hereunder
will indemnify and hold harmless each of such persons from any breaches or violations of this subsection 2.15.2.

 

3.             Sponsor
Registration Statement

 

3.1           With
respect to the Sponsor Shares and the Sponsor Warrants (jointly, the “Sponsor Securities”), the following provisions
shall apply instead of Section 2.2, Section 2.3, Section 2.4 and Section 2.5. The Company agrees that, within thirty
(30) calendar days after the Closing Date (the “Filing Deadline”), the Company will file with the SEC (at the Company’s
sole cost and expense) a registration statement registering the resale of the Sponsor Securities (the “Sponsor Registration Statement”),
and the Company shall use its commercially reasonable efforts to have the Sponsor Registration Statement declared effective as soon as
practicable after the filing thereof, but no later than the earlier of (i) the sixtieth (60th) calendar day (or ninetieth
(90th) calendar day if the SEC notifies the Issuer that it will “review” the Registration Statement) following
the Closing and (ii) the tenth (10th) Business Day after the date the Issuer is notified (orally or in writing, whichever
is earlier) by the SEC that the Registration Statement will not be “reviewed” or will not be subject to further review (such
earlier date, the “Effectiveness Date”); provided, however, that the Company’s obligations to include
the Sponsor Securities in the Sponsor Registration Statement are contingent upon the Sponsor furnishing in writing to the Company such
information regarding the Sponsor, the securities of the Company held by the Sponsor and the intended method of disposition of the Sponsor
Securities as shall be reasonably requested by the Company to effect the registration of the Sponsor Securities, and the Sponsor shall
execute such documents in connection with such registration as the Company may reasonably request that are customary of a selling shareholder
in similar situations. For purposes of clarification, any failure by the Company to file the Sponsor Registration Statement by the Filing
Deadline or to effect such Sponsor Registration Statement by the Effectiveness Date shall not otherwise relieve the Company of its obligations
to file or effect the Sponsor Registration Statement as set forth above in this Section 3.

 

    15

     

    

  

3.2            The
Company shall, upon reasonable request, inform the Sponsor as to the status of the registration effected by the Company pursuant to this
Section 3. At its expense the Company shall:

 

3.2.1
except for such times as the Company is permitted hereunder to suspend the use of the prospectus forming part of the Sponsor Registration
Statement, use its commercially reasonable efforts to keep such registration, and any qualification, exemption or compliance under state
securities laws which the Company determines to obtain, continuously effective with respect to the Sponsor, and to keep the applicable
Sponsor Registration Statement or any subsequent shelf registration statement free of any material misstatements or omissions, until the
earlier of the following: (i) the Sponsor ceases to hold any Sponsor Securities, and (ii) the date all Sponsor Securities held
by the Sponsor may be sold without restriction under Rule 144 and 145, including any volume and manner of sale restrictions under
Rule 144 and 145 and without the requirement for the Company to be in compliance with the current public information required under
Rule 144(c)(1) (or Rule 144(i)(2), if applicable);

 

3.2.2               advise
the Sponsor as expeditiously as possible, but in any event within five (5) Business Days:

 

		(a)	when the Sponsor Registration Statement or any post-effective amendment thereto has become effective;

 

		(b)	of the issuance by the SEC of any stop order suspending the effectiveness of the Sponsor Registration
Statement or the initiation of any proceedings for such purpose; and

 

		(c)	of the receipt by the Company of any notification with respect to the suspension of the qualification
of the Sponsor Securities included therein for sale in any jurisdiction or the initiation or threatening of any proceeding for such purpose.

 

    16

     

    

 

 

3.2.3            use
its commercially reasonable efforts to obtain the withdrawal of any order suspending the effectiveness of the Sponsor Registration Statement
as soon as reasonably practicable;

 

3.2.4            upon
the occurrence of any event that requires the making of any changes in the Sponsor Registration Statement or prospectus so that, as of
such date, the statements therein are not misleading and do not omit to state a material fact required to be stated therein or necessary
to make the statements therein (in the case of a prospectus, in light of the circumstances under which they were made) not misleading,
except for such times as the Company is permitted hereunder to suspend, and has suspended, the use of a prospectus forming part of the
Sponsor Registration Statement, the Company shall use its commercially reasonable efforts to as soon as reasonably practicable prepare
a post-effective amendment to the Sponsor Registration Statement or a supplement to the related prospectus, or file any other required
document so that, as thereafter delivered to purchasers of the Sponsor Securities included therein, such prospectus will not include any
untrue statement of a material fact or omit to state any material fact necessary to make the statements therein, in the light of the circumstances
under which they were made, not misleading; and

 

3.2.5            Notwithstanding
anything to the contrary in this Agreement, the Company shall not have any obligation to prepare any prospectus supplement, participate
in any due diligence, execute any agreements or certificates or deliver legal opinions or obtain comfort letters in connection with any
sales of the Sponsor Securities under the Sponsor Registration Statement in an underwritten offering.

 

3.3            Notwithstanding
anything to the contrary in this Agreement, the Company shall be entitled to delay or postpone the effectiveness of the Sponsor Registration
Statement, and from time to time to require the Sponsor not to sell under the Sponsor Registration Statement or to suspend the effectiveness
thereof, if the negotiation or consummation of a transaction by the Company or its subsidiaries is pending or an event has occurred, which
negotiation, consummation or event the Company Board reasonably believes, upon the advice of legal counsel (which may be in-house legal
counsel), would require additional disclosure by the Company in the Sponsor Registration Statement of material information that the Company
has a bona fide business purpose for keeping confidential and the non-disclosure of which in the Sponsor Registration Statement would
be expected, in the reasonable determination of the Company Board, upon the advice of legal counsel (which
may be in-house legal counsel), to cause the Sponsor Registration Statement to fail to comply with applicable disclosure requirements
(each such circumstance, a “Suspension Event”); provided, however, that the Company may not delay or suspend
the Sponsor Registration Statement on more than two occasions or for more than ninety (90) consecutive calendar days, or more than one
hundred and twenty (120) total calendar days, in each case during any twelve (12)-month period. Upon receipt of any written notice from
the Company of the happening of any Suspension Event during the period that the Sponsor Registration Statement is effective or if as a
result of a Suspension Event the Sponsor Registration Statement or related prospectus contains any untrue statement of a material fact
or omits to state any material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances
under which they were made (in the case of the prospectus) not misleading, the Sponsor agrees that (i) it will immediately discontinue
offers and sales of the Sponsor Securities under the Sponsor Registration Statement (excluding, for the avoidance of doubt, sales conducted
pursuant to Rule 144) until the Sponsor receives copies of a supplemental or amended prospectus (which the Company agrees to promptly
prepare) that corrects the misstatement(s) or omission(s) referred to above and receives notice that any post-effective amendment
has become effective or unless otherwise notified by the Company that it may resume such offers and sales, and (ii) it will maintain
the confidentiality of any information included in such written notice delivered by the Company unless otherwise required by law or subpoena.
If so directed by the Company, the Sponsor will deliver to the Company or, in the Sponsor’s sole discretion destroy, all copies
of the prospectus covering the Sponsor Securities in the Sponsor’s possession; provided, however, that this obligation to
deliver or destroy all copies of the prospectus covering the Sponsor Securities shall not apply (i) to the extent the Sponsor is
required to retain a copy of such prospectus (a) in order to comply with applicable legal, regulatory, self-regulatory or professional
requirements or (b) in accordance with a bona fide pre-existing document retention policy or (ii) to copies stored electronically
on archival servers as a result of automatic data back-up.

 

    17

     

    

 

4.              Lock-Up.

 

4.1            Lock-up.
Subject to Section 4.2, (i) all Holders agree that they shall not Transfer any Holder Lock-up Shares or any instruments exercisable
or exchangeable for, or convertible into, Holder Lock-up Shares (including without limitation the Continuing Options) until the end of
the applicable Holder Lock-up Period; (ii) the Sponsor agrees that it shall not Transfer any Sponsor Shares or Sponsor Warrants,
or any instruments exercisable or exchangeable for, or convertible into, Holder Lock-up Shares until the end of the Sponsor Lock-up Period
(save pursuant to the terms of any letter agreement between the Sponsor, the Company and BOA); and (iii) the Company Executives agree
that they shall not Transfer any Company Executive Shares or any instruments exercisable or exchangeable for, or convertible into, Company
Executive Shares until the end of the Company Executive Lock-up Period (collectively, the “Lock-up”).

 

4.2            Permitted
Transfers.

 

4.2.1.            Notwithstanding
the provisions set forth in Section 4.1, each Holder, the Sponsor, each Company Executive and each of their Permitted Transferees
may Transfer the Holder Lock-up Shares, the Sponsor Shares or the Company Executive Shares, as applicable, during the Holder Lock-up Period,
the Sponsor Lock-up Period or the Company Executive Lock-up Period, as applicable, (a) if such Holder or Company Executive is an
individual, (i) to an immediate family member, a charitable organization or a trust or other entity formed for estate planning purposes
for the benefit of an immediate family member, (ii) by will, testamentary document, intestacy or by virtue of laws of descent and
distribution upon the death of such Holder or Company Executive, or (iii) pursuant to a qualified domestic relations order or in
connection with a divorce settlement or any related court order, (b) if such Holder is a corporation, limited liability company,
partnership, trust or other entity, or in the case of the Sponsor, (i) to any shareholder, member, partner or trust beneficiary as
part of a distribution, or (ii) to any corporation, partnership or other entity that is an affiliate (as defined in Rule 405
of the Securities Act of 1933, as amended) of such Holder or Sponsor, as the case may be, (c) pursuant to a bona fide third-party
tender offer, merger, stock sale, recapitalization, consolidation or other transaction that results in a change in control of the Company
or results in the directors of the Company as of immediately prior to such transaction ceasing to comprise a majority of the Board of
Directors; provided that in the event that such tender offer, merger, recapitalization, consolidation or other such transaction
is not completed, the Shares subject to the Lock-up shall remain subject to the Lock-up, (d) if such Shares were acquired by such
Holder, the Sponsor or Company Executive in open market transactions following the date hereof, (f) to the Company in connection
with the “net” or “cashless” exercise of options or other rights to purchase Shares held by such Holder or Company
Executive in satisfaction of any tax withholding or exercise price obligations through cashless surrender or otherwise; provided
that any Shares issued upon exercise of such option or other rights shall remain subject to the terms of this Agreement;; provided,
however, that, in the case of clauses (a) and (b), such transferees shall execute a Joinder Agreement; and provided further
with respect to clauses (a) and (b), that any such transfer shall not involve a disposition for value.

 

    18

     

    

 

4.2.2            Notwithstanding
anything to the contrary herein, the Sponsor and the Company Executives may enter into a written plan meeting the requirements of Rule 10b5-1
under the Exchange Act (a “Rule 10b5-1 Plan”) after the date of this Agreement relating to the sale of
any Sponsor Shares or Sponsor Warrants, or Company Executive Shares, as applicable, provided that the securities subject to such
plan may not be transferred until after the expiration of the Sponsor Lock-up Period or Company Executive Lock-up Period, as applicable;
provided further, that no filing by the undersigned, the Company or any other person under the Exchange Act or other public announcement
in connection with the establishment or existence of such plan shall be required or shall be made voluntarily prior to the expiration
of such Sponsor Shares, or Company Executive Shares, as applicable.

 

5.              Director
nomination rights.

 

5.1.1         Each
Party shall take all such action within its power as may be necessary or appropriate, and each of the Sponsor and each Major Shareholder
listed on ‎Schedule 1 attached hereto agrees to vote, or cause to be voted, all of their respective Shares at any meeting (or
written consent) of the shareholders of the Company with respect to the election of directors, such that effective immediately after the
Effective Time, the Company Board consists of seven (7) directors consistent with the Business Combination Agreement, the members
of which shall be nominated and appointed in accordance with Clauses 5.1.2 to 5.1.7 (inclusive).

 

5.1.2         The
individuals occupying the roles of chief executive officer and chief growth officer (the “Executives”) shall each be
entitled to sit on the Company Board immediately after the Effective Time, and may not be replaced with any individual without the prior
written consent of the Company and the Sponsor. Neither the Company nor the Sponsor shall unreasonably withhold, condition or delay its
consent to the replacement of an Executive referred to in this clause with any individual that is hired by the Company by way of replacement
as a result of the death, disability or termination of employment for cause by the Company of an Executive.

 

    19

     

    

 

5.1.3         Prior
to the time at which the Registration Statement / Proxy Statement is declared effective under the Securities Act, the Sponsor shall, have
the right to designate two (2)individuals to serve on the Company Board immediately after the Effective Time, in each case, on the terms
of the Business Combination Agreement and the Transaction Support Agreements.

 

5.1.4         Prior
to the time at which the Registration Statement / Proxy Statement is declared effective under the Securities Act, certain of the Major
Shareholder listed on ‎Schedule 1 attached hereto] shall, have the right to designate five (5) individuals to serve on
the Company Board immediately after the Effective Time (including the Executives), in each case, on the terms of the Business Combination
Agreement and the Transaction Support Agreements.

 

5.1.5         Prior
to the time at which the Registration Statement / Proxy Statement is declared effective under the Securities Act, the members of the Company
Board shall by majority votedesignate at least one (1) individual to serve on the Company Board as an independent director immediately
after the Effective Time who shall be independent, and qualified to serve on the audit committee of the Board, under the applicable rules of
the NYSE (or any applicable exchange on which the Company’s securities may be listed) and the SEC (including Rule 10A-3 of
the Exchange Act).

 

5.1.6         Notwithstanding
the foregoing or anything to the contrary herein, unless otherwise agreed in writing by the Company, in no event shall there be less than
four (4) members of the Company Board that would qualify as “independent directors” under the listing rules of NYSE
(or any applicable exchange on which the Company’s securities may be listed) immediately after the Effective Time.

 

5.1.7         Prior
to the time at which the Registration Statement / Proxy Statement is declared effective under the Securities Act, the Company shall designate
each director that will serve on the compensation committee, the audit committee and the nominating committee of the Post-Closing Company
Board immediately after the Effective Time, subject to applicable listing rules of NYSE and applicable Federal Securities Laws.

 

6.              Miscellaneous.

 

6.1            Effectiveness;
Termination of Previous Agreement. This Agreement shall become effective as of the Closing and prior thereto shall be of no force
or effect. If the Business Combination Agreement is terminated in accordance with its terms prior to the Closing, this Agreement shall
automatically terminate and be of no force or effect.

 

6.2            Further
Assurances. Each of the parties hereto shall perform such further acts and execute such further documents as may reasonably be necessary
to carry out and give full effect to the provisions of this Agreement and the intentions of the parties as reflected thereby.

 

    20

     

    

 

6.3            Governing
Law; Exclusive Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by and construed according to the laws of the
State of Delaware, without regard to the conflict of laws provisions thereof. Any dispute arising under or in relation to this Agreement
shall be resolved solely and exclusively in the Court of Chancery of the State of Delaware, provided, that if subject matter jurisdiction
over the matter that is the subject of the legal proceeding is vested exclusively in the U.S. federal courts, such legal proceeding shall
be heard in the U.S. District Court for the District of Delaware, and each of the parties hereby submits irrevocably to the jurisdiction
of such court. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH CANNOT BE WAIVED, EACH OF THE PARTIES IRREVOCABLY AND UNCONDITIONALLY
WAIVES ANY RIGHT TO TRIAL BY JURY IN RESPECT TO ANY ACTION DIRECTLY OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH OR RELATING
TO THIS AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS AGREEMENT.

 

6.4            Successors
and Assigns; Assignment. Except as otherwise expressly limited herein (including Section 4.1), the provisions hereof shall inure
to the benefit of, and be binding upon, the successors, assigns, heirs, executors, and administrators of the parties hereto. Except as
expressly permitted under Section 2.11 above, none of the rights, privileges, or obligations set forth in, arising under, or created
by this Agreement may be assigned or transferred without the prior consent in writing of each party to this Agreement, with the exception
of (a) assignments and transfers between the Major Shareholders, as the case may be, and (b) assignments and transfers from
a Shareholder to any other entity which controls, is controlled by, or is under common control with, such Shareholder, and as to any Shareholder
which is a partnership, assignments and transfers to its partners and to affiliated partnerships managed by the same management company
or managing general partner or by an entity which controls, is controlled by, or is under common control with, such management company
or managing general partner (collectively “Permitted Transferees”). Notwithstanding the foregoing, (a) any Permitted
Transferee shall, in connection with their purchase of Shares, execute a Joinder Agreement to be entered into between the Company and
such Permitted Transferee at the time of the applicable transfer, pursuant to which such Permitted Transferee shall be deemed to be a
party to this Agreement, and (b) any other person owning or acquiring Registrable Securities of the Company may, at the Company’s
request, execute a Joinder Agreement with the Company, pursuant to which such person shall be deemed to be a party to this Agreement.
Unless otherwise noted in the applicable Joinder Agreement, each Permitted Transferee shall be deemed a Holder.

 

6.5            Entire
Agreement; Amendment and Waiver. This Agreement and the Schedules hereto constitute the full and entire understanding and agreement
between the parties with regard to the subject matters hereof and thereof and supersede all prior agreement and understanding, both oral
and written between parties with respect to the subject matter of this Agreement,. Any term of this Agreement may be amended and the observance
of any term hereof may be waived (either prospectively or retroactively and either generally or in a particular instance) with the written
consent of the Company and the Major Shareholders holding a majority of the Registrable Securities.

 

6.6            Termination.
This Agreement will automatically terminate upon the earlier to occur of (i) any acquisition of the Company, including by way of
merger or consolidation, after the Business Combination, or (ii) the date as of which there shall be no Registrable Securities outstanding.

 

    21

     

    

 

6.7            Notices, etc.
All notices and other communications required or permitted hereunder to be given to a party to this Agreement shall be in writing and
shall be mailed by registered mail, postage prepaid, or otherwise delivered by electronic mail, hand or by messenger, addressed to such
party’s address as set forth in the shareholders register maintained by the Company or at such other address with respect to a party
as such party shall notify each other party in writing as above provided. Any notice sent in accordance with this Section 6.7 shall
be effective (i) if mailed, seven (7) Business Days after mailing, (ii) if
sent by messenger, upon delivery, and (iii) if sent via email, upon transmission and electronic confirmation of receipt or, if transmitted
and received on a non-Business Day, on the first Business Day following transmission and
electronic confirmation of receipt.

 

6.8            Delays
or Omissions. No delay or omission to exercise any right, power, or remedy accruing to any party upon any breach or default under
this Agreement, shall be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any waiver, permit, consent,
or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part
of any party of any provisions or conditions of this Agreement, must be in writing and shall be effective only to the extent specifically
set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any of the parties, shall be cumulative
and not alternative.

 

6.9            Severability.
If any provision of this Agreement is held by a court of competent jurisdiction to be unenforceable under applicable law, then such provision
shall be excluded from this Agreement and the remainder of this Agreement shall be interpreted as if such provision were so excluded and
shall be enforceable in accordance with its terms; provided that in such event this Agreement shall be interpreted so as to give
effect, to the greatest extent consistent with and permitted by applicable law, to the meaning and intention of the excluded provision
as determined by such court of competent jurisdiction.

 

6.10          Counterparts;
Electronic Execution. This Agreement may be executed in any number of counterparts (including by facsimile or electronic transmission
(including .pdf file, .jpeg file, Adobe Sign, or DocuSign), each of which shall be deemed an original and enforceable against the parties
actually executing such counterpart, and all of which together shall constitute one and the same instrument. Delivery of an executed counterpart
of a signature page to this Agreement by electronic, facsimile or portable document format shall be effective as delivery of a mutually
executed counterpart to this Agreement and shall have the same legal validity and enforceability as a manually executed signature to the
fullest extent permitted by applicable law.

 

6.11          Aggregation
of Shares. All Shares held by affiliated entities or persons (and for the avoidance of doubt, the Shares held by each of the entities
set forth on 0 which are grouped under a titled group) shall be aggregated together for the purpose of determining the availability
of any rights under this Agreement.

 

6.12          No
Third Party Beneficiaries. Except as expressly provided in this Agreement, this Agreement (including the documents and instruments
referred to herein) is not intended to confer on any person other than the parties hereto any rights, remedies, obligations or liabilities
hereunder.

 

    22

     

    

 

6.13          Mutual
Drafting. This Agreement is the joint product of the parties hereto and each provision hereof has been subject to the mutual consultation,
negotiation and agreement of the parties and shall not be construed for or against any party hereto.

 

[Remainder of page intentionally left blank.]

 

    23

     

    

 

IN WITNESS WHEREOF the parties
have signed this Investors Rights Agreement as the date first hereinabove set forth.

 

	SELINA HOLDING COMPANY, UK SOCIETAS	 
	 	 	 
	By:	 	 
	Name:	 	 
	Title:	 	 

 

[Signature Pages Continue]

 

    	 		 

     

    

 

Shareholders:

 

[●]

 

	By:	 	    

 

	Name:	 	    
	 	 	 
	Title:	 	 

 

	Address:	 	 
	 	 	 
	 	 

 

 

[●]

 

	By:	 	    

 

	Name:	 	    
	 	 	 
	Title:	 	 

 

	Address:	 	 
	 	 	 
	 	 

 

 

[●]

 

	By:	 	    

 

	Name:	 	    
	 	 	 
	Title:	 	 

 

	Address:	 	 
	 	 	 
	 	 

 

 

[●]

 

	By:	 	    

 

	Name:	 	    
	 	 	 
	Title:	 	 

 

	Address:	 	 
	 	 	 
	 	 

 

    	 		 

     

    

 

BOA Acquisition Corp.

 

	By:	 	    

 

	Name:	 	    
	 	 	 
	Title:	Authorized Signatory	 

 

	Address:	[●]	 

 

Bet on America LLC

 

	By:	 	    

 

	Name:	 	    
	 	 	 
	Title:	Authorized Signatory	 

 

	Address:	[●]	 

 

    	 		 

     

    

 

Major Shareholders

 

    	 		 

     

    

 

Exhibit A

 

Form of Joinder Agreement

 

[Date]

 

Reference is hereby made to
the Investors’ Rights Agreement, dated [____], 2021 (the “IRA”), by and between Selina Holding Company, UK Societas,
(the “Company”), and the Shareholders named therein. Capitalized terms used herein and not otherwise defined herein
shall have the meanings ascribed to such terms in the IRA.

 

Each of the undersigned hereby
acknowledges, agrees and confirms that, by its execution of this Joinder Agreement, it shall be deemed to be a party to the IRA as if
it were an original signatory thereto and hereby expressly assumes, and agrees to perform and discharge, all of the obligations and liabilities
of a party thereto as the case may be, under the IRA. All references in the IRA to the “Shareholders”, “Holders”
or “Major Shareholders”, as the case may be, shall hereafter include each of the undersigned and their respective successors,
as applicable.

 

Each of the undersigned hereby
agrees to promptly execute and deliver any and all further documents and take such further action as the Company, the Shareholders or
any undersigned party may reasonably require to effect the purpose of this Joinder Agreement.

 

This Joinder Agreement shall
be governed by and construed according to the laws of the State of Delaware, without regard to the conflict of laws provisions thereof.
Any dispute arising under or in relation to this Joinder Agreement shall be resolved solely and exclusively in the Court of Chancery of
the State of Delaware, provided, that if subject matter jurisdiction over the matter that is the subject of the legal proceeding is vested
exclusively in the U.S. federal courts, such legal proceeding shall be heard in the U.S. District Court for the District of Delaware,
and each of the parties hereby submits irrevocably to the jurisdiction of such court. TO THE EXTENT NOT PROHIBITED BY APPLICABLE LAW WHICH
CANNOT BE WAIVED, EACH OF THE PARTIES IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT TO TRIAL BY JURY IN RESPECT TO ANY ACTION DIRECTLY
OR INDIRECTLY ARISING OUT OF, UNDER OR IN CONNECTION WITH OR RELATING TO THIS JOINDER AGREEMENT OR THE TRANSACTIONS CONTEMPLATED BY THIS
JOINDER AGREEMENT.

 

[Signature Pages Follow]

 

    	 		 

     

    

 

IN
WITNESS WHEREOF, the parties hereto have executed this Joinder Agreement as of the date herein above set forth.

 

The Company:

 

Selina Holding Company, UK Societas

 

	 	 	 
	By:	 	 	By:	[     ]
	Title:	 	 	Title:	[       ]
	 	 	 	Address	 
	 	 	 	 	 
	[Permitted Transferees]:	 	 	 
	 	 	 	 	 
	 	 	 	 
	[       ]	 	 	 	 
	 	 	 	 	 
	By:	         	 	 	 

 

    	 		 

     

    

 

Exhibit B

 

FORM OF IRREVOCABLE TRANSFER AGENT INSTRUCTIONS

 

As of _________, ____

 

[Insert Name of Transfer Agent]

[Address]

[Address]

 

Attn: _________________

 

Ladies and Gentlemen:

 

Reference is made to that certain Investors’
Rights Agreement, dated as of _____________, ___ (the “Agreement”), by and among Selina Holding Company, UK Societas
(the “Company”), and the shareholders named on the signature pages thereto (collectively, and including permitted
transferees, the “Holders”).

 

This letter shall serve as our irrevocable authorization
and direction to you (provided that you are the transfer agent of the Company at such time and the conditions set forth in this letter
are satisfied), subject to any stop transfer instructions that we may issue to you from time to time, if any, to issue certificates representing
shares of Common Stock upon transfer or resale of the Shares (as defined in the Agreement).

 

You acknowledge
and agree that so long as you have received written confirmation from the Company’s legal counsel that either (1) the
Shares have been sold in conformity with Rule 144 under the Securities Act (“Rule 144”) or (2) the Shares
are eligible for sale under Rule 144, without the requirement for the Company to be in compliance with the current public information
required under Rule 144 as to such securities and without volume or manner-of-sale restrictions within two (2) trading days
of your receipt of a notice of transfer or Shares, you shall issue the certificates representing the Shares registered in the names of
such Holders or transferees, as the case may be, and such certificates shall not bear any legend restricting transfer of the Shares thereby
and should not be subject to any stop-transfer restriction

 

Please be advised that the Holders are relying
upon this letter as an inducement to enter into the Agreement and, accordingly, each Holder is a third party beneficiary to these instructions.

 

    	 		 

     

    

 

Please execute this letter in the space indicated
to acknowledge your agreement to act in accordance with these instructions.

 

	 	Very truly yours,
	 	 
	 	SELINA HOLDING COMPANY, UK SOCIETAS.
	 	 
	 	By:	                
	 	Name:	 
	 	Title:	 

 

	Acknowledged and Agreed:	 
	 	 
	[INSERT NAME OF TRANSFER AGENT]	 
	 	 
	By:	 	 
	Name:	         	 
	Title: 	 	 

 

Date: _________________, ______Exhibit 10.2

 

Confidential

 

SUBSCRIPTION AGREEMENT

 

Selina Holding Company, UK Societas

6th Floor 2 London Wall Place

Barbican, London, EC2Y 5AU, United Kingdom

 

BOA Acquisition Corp.

200 Virginia Ave NW, Suite T23 Management Office

Washington, DC 20037

 

Ladies and Gentlemen:

 

This Subscription Agreement
(this “Subscription Agreement”) is being entered into as of the date set forth on the signature page hereto (the
 “Subscription Date”), by and between Selina Holding Company, UK Societas (the “Issuer”), and the
undersigned subscriber (the “Investor”), in connection with the Business Combination Agreement, dated as of the date
hereof (as may be amended, supplemented or otherwise modified from time to time, the “Transaction Agreement”), by
and among BOA Acquisition Corp., a Delaware corporation (“BOA”), the Issuer and Samba Merger Sub, Inc., a
Delaware corporation and a direct, wholly-owned subsidiary of the Issuer (“Merger Sub”), pursuant to which, among
other things, Merger Sub will merge with and into BOA, with BOA continuing as the surviving company in the merger and, after giving effect
to such merger, becoming a direct, wholly-owned subsidiary of the Issuer, on the terms and subject to the conditions set forth in the
Transaction Agreement (such merger and the other transactions contemplated by the Transaction Agreement, collectively, the “Transaction”).

 

In
connection with the Transaction, the Issuer is seeking commitments from interested investors to purchase and subscribe for, simultaneously
with the closing of the Transaction, the Issuer’s ordinary shares of $0.01 each (the “Shares”), in a
private placement for a purchase price of $10.00 per ordinary share (the “Per Share Purchase Price”). On or about
the date of this Subscription Agreement, the Issuer is entering into separate subscription agreements on substantially the same terms
(the “Other Subscription Agreements”, and together with this Subscription Agreement, the “Subscription Agreements”)
with certain other investors (the “Other Investors”, and together with the Investor, the “PIPE Investors”),
pursuant to which the PIPE Investors, severally and not jointly, have agreed to purchase on the closing date of the Transaction, inclusive
of the Shares subscribed for by the Investor, an aggregate amount of up to [●], Shares, at the Per Share Purchase Price. The aggregate
purchase price to be paid by the Investor for the subscribed Shares (as set forth on the signature page hereto) is referred to herein
as the “Subscription Amount”.

 

In connection therewith,
and in consideration of the foregoing and the mutual representations, warranties and covenants, and subject to the conditions, set forth
herein, and intending to be legally bound hereby, each of the Investor and Issuer acknowledges and agrees as follows:

 

1.           Subscription.
As of the Subscription Date, the Investor hereby irrevocably subscribes for and agrees to purchase from the Issuer, and the Issuer agrees
to allot and issue and sell to the Investor, such number of Shares as is set forth on the signature page of this Subscription Agreement
at the Subscription Amount and on the terms provided for and subject to the conditions set forth herein. Notwithstanding anything contained
herein to the contrary, the Investor acknowledges and agrees that the Issuer reserves the right to accept or reject the Investor’s
subscription for the Shares for any reason or for no reason, in whole or in part, at any time prior to its acceptance, and the same shall
be deemed to be accepted by the Issuer only when this Subscription Agreement is signed by a duly authorized person by or on behalf of
the Issuer.

 

2.            Closing.

 

a.            The
closing of the sale, purchase and issuance of the Shares contemplated hereby (the “Closing”, and the date that the
Closing actually occurs, the “Closing Date”) is contingent upon the substantially concurrent consummation of the Transaction.
The Closing shall occur on the date of, and concurrently with, the effectiveness and closing of the Transaction (the “Transaction
Closing”) (but for the avoidance of doubt, shall occur after giving effect to the Capital Restructuring (as defined in the
Transaction Agreement)).

 

     

     

    

 

b.            The
Issuer shall deliver, or cause to be delivered, written notice to the Investor (the “Closing Notice”), that the Issuer
reasonably expects all conditions to the closing of the Transaction under the Transaction Agreement to be satisfied or waived on a date
that is not less than five (5) business days from the date of the Closing Notice, which Closing Notice shall contain wire instructions
for delivery of the Subscription Amount to the Issuer. At least three (3) business days prior to the anticipated closing date specified
in the Closing Notice (unless otherwise agreed to by the Issuer (with the prior written consent of BOA)), the Investor shall deliver
to the Issuer the aggregate Subscription Amount by wire transfer of United States dollars in immediately available funds to be held by
the Issuer in escrow until the Closing. The wire transfer shall identify the Investor, and unless otherwise agreed to by the Issuer,
the funds shall be wired from an account in the Investor’s name. The Issuer shall deliver to Investor (i) at the Closing,
the Shares, in book entry form and free and clear of any liens or other restrictions (other than those arising under the Issuer’s
constituent documents and applicable laws), in the name of the Investor (or its nominee), and (ii) as promptly as practicable after
the Closing, evidence from the Issuer’s transfer agent of the issuance of such Shares on and as of the Closing Date. If this Subscription
Agreement is terminated prior to the Closing and any funds have already been sent by the Investor to the Issuer, then promptly after
such termination, the Issuer shall promptly return such funds to the Investor. In the event that the consummation of the Transaction
does not occur on the anticipated closing date specified in the Closing Notice or within three (3) business days thereafter, unless
otherwise agreed to in writing by the Issuer, BOA and the Investor, the Issuer shall promptly (but in no event later than five (5) business
days after the anticipated closing date specified in the Closing Notice) return the Subscription Amount so delivered by the Investor
by wire transfer in immediately available funds to the account specified by the Investor, and any book entries representing Shares issued
in consideration thereof shall be deemed cancelled.

 

c.             On
the Closing Date, or promptly after the Closing, the Issuer shall issue and allot (or cause to be issued and allotted) a number of Shares
to the Investor set forth on the signature page to this Subscription Agreement, and subsequently cause such Shares to be registered
in book entry form in the name of the Investor on the Issuer’s share register; provided, however, that the obligation
to issue the Shares to the Investor is contingent upon the Issuer having received the Subscription Amount in full accordance with this
Section 2. For purposes of this Subscription Agreement, “business day” shall mean a day, other than a Saturday
or Sunday, on which commercial banks in both New York, New York and London, United Kingdom are open for the general transaction of business.

 

3.            Closing
Conditions.

 

a.            The
obligation of the parties hereto to consummate the sale, purchase and issuance of the Shares pursuant to this Subscription Agreement
is subject to the following conditions:

 

(i)                           no
applicable governmental authority shall have enacted, issued, promulgated, enforced or entered any judgment, order, law, rule or
regulation (whether temporary, preliminary or permanent) which is then in effect and has the effect of making consummation of the transactions
contemplated hereby illegal or otherwise restraining or prohibiting consummation of the transactions contemplated hereby; and

 

(ii)                          all
conditions precedent to the Transaction Closing set forth in Article 6 of the Transaction Agreement shall have been satisfied or
waived (which shall be deemed satisfied if mutually determined by the parties to the Transaction Agreement and other than those conditions
under the Transaction Agreement that, by their nature, are to be satisfied at the Transaction Closing).

 

b.            The
obligation of the Issuer to consummate the sale and issuance of the Shares pursuant to this Subscription Agreement shall be subject to
the condition (which may be waived in writing by the Issuer (with the prior written consent of BOA, which such consent shall not be unreasonably
withheld)) that all representations and warranties of the Investor contained in this Subscription Agreement are true and correct in all
material respects at and as of the Closing Date (except for those representations and warranties that speak as of a specified earlier
date, which shall be so true and correct in all material respects as of such specified earlier date), and consummation of the Closing
shall constitute a reaffirmation by the Investor of each of the representations and warranties of the Investor contained in this Subscription
Agreement in all material respects as of the Closing Date (except those that speak as of a specified earlier date).

 

    2 

     

    

 

c.           The
obligation of the Investor to consummate the purchase of, and subscription for, the Shares pursuant to this Subscription Agreement shall
be subject to the condition (which may be waived in writing by the Investor) that all representations and warranties of the Issuer contained
in this Subscription Agreement shall be true and correct in all material respects at and as of the Closing Date (except for those representations
and warranties that speak as of a specified earlier date, which shall be so true and correct in all material respects as of such specified
earlier date), and consummation of the Closing shall constitute a reaffirmation by the Issuer of each of the representations and warranties
of the Issuer contained in this Subscription Agreement in all material respects as of the Closing Date (except those that speak as of
a specified earlier date).

 

4.            Further
Assurances. At the Closing, the parties hereto shall execute and deliver such additional documents and take such additional actions
as the parties reasonably may deem to be practical and necessary in order to consummate the subscription as contemplated by this Subscription
Agreement.

 

5.            Issuer’s
Representations and Warranties. The Issuer represents and warrants to the Investor that:

 

a.            As
of the Closing Date, the Issuer will be a public limited company (or UK Societas), in each case, validly existing under the laws of England
and Wales. The Issuer has all requisite power and authority to own, lease and operate its properties and conduct its business as presently
conducted and to enter into, deliver and perform its obligations under this Subscription Agreement.

 

b.            As
of the Closing Date, the Shares will be duly authorized and, when issued and delivered to the Investor against full payment therefor
in accordance with the terms of this Subscription Agreement, the Shares will be validly issued, fully paid up and will not have been
issued in violation of any preemptive or similar rights created under the Issuer’s articles of association (as amended on or prior
to the Closing Date) or under the Companies Act 2006.

 

c.            This
Subscription Agreement has been duly authorized, executed and delivered by the Issuer and, assuming that this Subscription Agreement
constitutes the valid and binding agreement of the Investor, this Subscription Agreement is enforceable against the Issuer in accordance
with its terms, except as may be limited or otherwise affected by (i) bankruptcy, insolvency, reorganization, moratorium or other
relevant laws relating to or affecting the rights of creditors generally, or (ii) principles of equity, whether considered at law
or equity.

 

d.            The
sale and issuance of the Shares and the compliance by the Issuer with all of the provisions of this Subscription Agreement and the consummation
of the transactions contemplated herein will not conflict with or result in a breach or violation of any of the terms or provisions of,
or constitute a default under, or result in the creation or imposition of any lien, charge or encumbrance upon any of the property or
assets of the Issuer or any of its subsidiaries pursuant to the terms of (i) any indenture, mortgage, deed of trust, loan agreement,
lease, license or other agreement or instrument to which the Issuer or any of its subsidiaries is a party or by which the Issuer or any
of its subsidiaries is bound or to which any of the property or assets of the Issuer is subject that would reasonably be expected to
have a material adverse effect on the business, financial condition or results of operations of the Issuer and its subsidiaries, taken
as a whole (a “Material Adverse Effect”) or materially affect the validity of the Shares or the legal authority of
the Issuer to comply in all material respects with the terms of this Subscription Agreement; (ii) result in any violation of the
provisions of the constitutional documents of the Issuer; or (iii) result in any violation of any statute or any judgment, order,
rule or regulation of any court or governmental agency or body, domestic or foreign, having jurisdiction over the Issuer or any
of its properties that would reasonably be expected to have a Material Adverse Effect or materially affect the validity of the Shares
or the legal authority of the Issuer to comply in all material respects with this Subscription Agreement.

 

e.           The
Issuer is not required to obtain any consent, waiver, authorization or order of, give any notice to, or make any filing or registration
with, any court or other governmental authority, self-regulatory organization or other person in connection with the execution, delivery
and performance by the Issuer of this Subscription Agreement (including, without limitation, the issuance of the Shares), other than
(i) filings with the SEC, (ii) filings required by applicable state securities laws, (iii) filings required by the New
York Stock Exchange, or such other applicable stock exchange on which the Issuer’s common equity is then listed (the “Stock
Exchange”), and (iv) the failure of which to obtain would not be reasonably likely to have, individually or in the aggregate,
a Material Adverse Effect.

 

    3 

     

    

 

f.            Assuming
the accuracy of the Investor’s representations and warranties set forth in Section 6, no registration under the Securities
Act is required for the offer and sale of the Shares by the Issuer to the Investor hereunder. The Shares (i) were not offered by
any form of general solicitation or general advertising and (ii) are not being offered in a manner involving a public offering under,
or in a distribution in violation of, the Securities Act, or any state securities laws.

 

g.            Other
than the Placement Agents (as defined below), the Issuer has not engaged any broker, finder, commission agent, placement agent or arranger
in connection with the sale of the Shares, and the Issuer is not under any obligation to pay any broker’s fee or commission in
connection with the sale of the Shares other than to the Placement Agents.

 

6.            Investor
Representations and Warranties. The Investor represents and warrants to the Issuer that:

 

a.            The
Investor (i) is a “qualified institutional buyer” (as defined in Rule 144A under the Securities Act) or an institutional
 “accredited investor” (within the meaning of Rule 501(a) under the Securities Act), in each case, satisfying the
applicable requirements set forth on Schedule A, (ii) is acquiring the Shares only for its own account and not for the account
of others, or if the Investor is subscribing for the Shares as a fiduciary or agent for one or more investor accounts, the Investor has
full investment discretion with respect to each such account, and the full power and authority to make the acknowledgements, representations
and agreements herein on behalf of each owner of each such account, and (iii) is not acquiring the Shares with a view to, or for
offer or sale in connection with, any distribution thereof in violation of the Securities Act (and shall provide the requested information
set forth on Schedule A). The Investor is not an entity formed for the specific purpose of acquiring the Shares.

 

b.            The
Investor acknowledges and agrees that the Shares are being offered in a transaction not involving any public offering within the meaning
of the Securities Act and that the offer and sale of the Shares have not been registered under the Securities Act. The Investor acknowledges
and agrees that the Shares may not be offered, resold, transferred, pledged or otherwise disposed of by the Investor absent an effective
registration statement under the Securities Act except (i) to the Issuer or a subsidiary thereof, (ii) to non-U.S. persons
pursuant to offers and sales that occur outside the United States within the meaning of Regulation S under the Securities Act or (iii) pursuant
to another applicable exemption from the registration requirements of the Securities Act, and in each of clauses (i) and (iii) in
accordance with any applicable securities laws of the states and other jurisdictions of the United States, and that any certificates
or book entries representing the Shares shall contain a restrictive legend or notation to such effect. The Investor acknowledges and
agrees that the Shares will be subject to transfer restrictions and, as a result of these transfer restrictions, the Investor may not
be able to readily offer, resell, transfer, pledge or otherwise dispose of the Shares and may be required to bear the financial risk
of an investment in the Shares for an indefinite period of time. The Investor acknowledges and agrees that the Shares will not be eligible
for offer, resale, transfer, pledge or disposition pursuant to Rule 144 promulgated under the Securities Act until at least one
year from the date that the Issuer files a Current Report on Form 6-K following the Closing Date that includes the “Form 10”
information required under applicable SEC rules and regulations. The Investor acknowledges and agrees that it has been advised to
consult legal counsel prior to making any offer, resale, transfer, pledge or disposition of any of the Shares.

 

c.            The
Investor acknowledges and agrees that the Investor is subscribing for and purchasing the Shares from the Issuer. The Investor further
acknowledges that there have been no representations, warranties, covenants and agreements made to the Investor by or on behalf of the
Issuer or any of its affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of
the foregoing or any other person or entity, expressly or by implication, other than those representations, warranties, covenants and
agreements of the Issuer expressly set forth in Section 5 of this Subscription Agreement. The Investor acknowledges that
certain information provided by the Issuer and BOA was based on projections and such projections were based on assumptions and estimates
that are inherently uncertain and are subject to a wide variety of significant business, economic and competitive risks and uncertainties
(including without limitation those included in the investor presentation provided to the Investor) that could cause actual results to
differ materially from those contained in the projections. The Investor further acknowledges that the information provided to the Investor
is preliminary and subject to change.

 

d.            The
Investor’s acquisition and holding of the Shares will not constitute or result in a non-exempt prohibited transaction under Section 406
of the Employee Retirement Income Security Act of 1974, as amended, Section 4975 of the Internal Revenue Code of 1986, as amended,
or any applicable similar law.

 

    4 

     

    

 

e.            The
Investor acknowledges and agrees that the Investor has received access to, and has had an adequate opportunity to review, such financial
and other information as the Investor deems necessary in order to make an investment decision with respect to the Shares, including,
without limitation, with respect to the Issuer, the Transaction and the business of the Issuer and its subsidiaries and made its own
assessment and is satisfied concerning the relevant tax and other economic considerations relevant to the Investor’s investment
in the Shares. Without limiting the generality of the foregoing, the Investor acknowledges that it has reviewed the documents made available
by or on behalf of the Issuer. The Investor acknowledges and agrees that the Investor and the Investor’s professional advisor(s),
if any, have had the full opportunity to ask such questions, receive such answers and obtain such information as the Investor and such
Investor’s professional advisor(s), if any, have deemed necessary to make an investment decision with respect to the Shares.

 

f.            The
Investor became aware of this offering of the Shares solely by means of direct contact between the Investor and the Issuer, BOA or a
representative of the Issuer or BOA, and the Shares were offered to the Investor solely by direct contact between the Investor and the
Issuer, BOA or a representative of the Issuer or BOA. The Investor did not become aware of this offering of the Shares, nor were the
Shares offered to the Investor, by any other means. The Investor acknowledges that the Shares (i) were not offered by any form of
general solicitation or general advertising and (ii) are not being offered in a manner involving a public offering under, or in
a distribution in violation of, the Securities Act, or any state securities laws. The Investor acknowledges that it is not relying upon,
and has not relied upon, any statement, representation or warranty made by any person, firm or corporation (including, without limitation,
the Issuer, BOA, the Placement Agents, any of their respective affiliates or any control persons, officers, directors, employees, partners,
agents or representatives of any of the foregoing), other than the representations and warranties of the Issuer contained in Section 5
of this Subscription Agreement, in making its investment or decision to invest in the Issuer.

 

g.           The
Investor acknowledges that it is aware that there are substantial risks incident to the purchase and ownership of the Shares (including,
without limitation, the risks included in the investor presentation provided to Investor). The Investor has such knowledge and experience
in financial and business matters as to be capable of evaluating the merits and risks of an investment in the Shares, and the Investor
has sought such accounting, legal and tax advice as the Investor has considered necessary to make an informed investment decision.

 

h.           Alone,
or together with any professional advisor(s), the Investor has adequately analyzed and fully considered the risks of an investment in
the Shares and determined that the Shares are a suitable investment for the Investor and that the Investor is able at this time and in
the foreseeable future to bear the economic risk of a total loss of the Investor’s investment in the Issuer. The Investor acknowledges
specifically that a possibility of total loss exists. The Investor will not look to the Placement Agents for all or part of any such
loss or losses the Investor may suffer, is able to sustain a complete loss on its investment in the Shares, has no need for liquidity
with respect to its investment in the Shares and has no reason to anticipate any change in circumstances, financial or otherwise, which
may cause or require any sale or distribution of all or any part of the Shares.

 

i.            In
making its decision to purchase the Shares, the Investor has relied solely upon independent investigation made by the Investor. Without
limiting the generality of the foregoing, the Investor has not relied on any statements or other information provided by or on behalf
of the Placement Agents or any of their respective affiliates or any control persons, officers, directors, employees, partners, agents
or representatives of any of the foregoing concerning the Issuer, BOA, the Transaction, the Transaction Agreement, this Subscription
Agreement or the transactions contemplated hereby or thereby, the Shares or the offer and sale of the Shares.

 

j.            The
Investor acknowledges that the Placement Agents (i) have not provided the Investor with any information or advice with respect to
the Shares, (ii) have not made any representation, express or implied as to the Issuer, BOA, the Issuer’s credit quality,
the Shares or the Investor’s purchase of the Shares, (iii) have not acted as the Investor’s financial advisor or fiduciary
in connection with the issue and purchase of Shares, (iv) may have acquired, or may acquire, non-public information with respect
to the Issuer, which the Investor agrees need not be provided to it, (v) may have existing or future business relationships with
the Issuer and BOA (including, but not limited to, lending, depository, risk management, advisory and banking relationships) and will
pursue actions and take steps that it deems necessary or appropriate to protect its interests arising therefrom without regard to the
consequences for a holder of Shares, and that certain of these actions may have material and adverse consequences for a holder of Shares.

 

    5 

     

    

 

k.            The
Investor acknowledges that it has not relied on the Placement Agents in connection with their determination as to the legality of its
acquisition of the Shares or as to the other matters referred to herein and the Investor has not relied on any investigation that the
Placement Agents, any of their affiliates or any person acting on its behalf have conducted with respect to the Shares, the Issuer or
BOA. The Investor further acknowledges that it has not relied on any information contained in any research reports prepared by the Placement
Agents or any of their respective affiliates.

 

l.            The
Investor acknowledges and agrees that no governmental agency has passed upon or endorsed the merits of the offering of the Shares or
made any findings or determination as to the fairness of this investment.

 

m.           The
Investor, if not an individual, has been duly formed or incorporated and is validly existing and is in good standing under the laws of
its jurisdiction of formation or incorporation, with power and authority to enter into, deliver and perform its obligations under this
Subscription Agreement.

 

n.            The
execution, delivery and performance by the Investor of this Subscription Agreement are within the powers of the Investor, have been duly
authorized and will not constitute or result in a breach or default under or conflict with any order, ruling or regulation of any court
or other tribunal or of any governmental commission or agency, or any agreement or other undertaking, to which the Investor is a party
or by which the Investor is bound, and, if the Investor is not an individual, will not conflict with or violate any provisions of the
Investor’s organizational documents, including, without limitation, its incorporation or formation papers, bylaws, indenture of
trust or partnership or operating agreement, as may be applicable. The signature on this Subscription Agreement is genuine, and the signatory,
if the Investor is an individual, has legal competence and capacity to execute the same or, if the Investor is not an individual, the
signatory has been duly authorized to execute the same, and this Subscription Agreement has been duly executed and delivered by the Investor
and constitutes a legal, valid and binding obligation of the Investor, enforceable against the Investor in accordance with its terms
except as may be limited or otherwise affected by (i) bankruptcy, insolvency, fraudulent conveyance, reorganization, moratorium
or other laws relating to or affecting the rights of creditors generally, and (ii) principles of equity, whether considered at law
or equity.

 

o.            The
Investor is not (i) a person or entity named on the List of Specially Designated Nationals and Blocked Persons administered by the
U.S. Treasury Department’s Office of Foreign Assets Control (“OFAC”) or in any Executive Order issued by the
President of the United States and administered by OFAC (“OFAC List”), or a person or entity prohibited by any OFAC
sanctions program, (ii) a Designated National as defined in the Cuban Assets Control Regulations, 31 C.F.R. Part 515, or (iii) a
non-U.S. shell bank or providing banking services indirectly to a non-U.S. shell bank. The Investor agrees to provide law enforcement
agencies, if requested thereby, such records as required by applicable law, provided that the Investor is permitted to do so under applicable
law. If the Investor is a financial institution subject to the Bank Secrecy Act (31 U.S.C. Section 5311 et seq.) (the “BSA”),
as amended by the USA PATRIOT Act of 2001 (the “PATRIOT Act”), and its implementing regulations (collectively, the
 “BSA/PATRIOT Act”), the Investor maintains policies and procedures reasonably designed to comply with applicable obligations
under the BSA/PATRIOT Act. To the extent required, it maintains policies and procedures reasonably designed for the screening of its
investors against the OFAC sanctions programs, including, without limitation, the OFAC List. To the extent required by applicable law,
the Investor maintains policies and procedures reasonably designed to ensure that the funds held by the Investor and used to purchase
the Shares were legally derived.

 

p.            The
Investor acknowledges that no disclosure or offering document has been prepared by UBS Securities LLC or PJT Partners LP or any of their
respective affiliates (collectively, the “Placement Agents”) in connection with the offer and sale of the Shares.

 

q.           The
Investor acknowledges that neither Placement Agent, nor any of their respective affiliates nor any control persons, officers, directors,
employees, partners, agents or representatives of any of the foregoing have made any independent investigation with respect to the Issuer,
BOA or their respective subsidiaries or any of their respective businesses, or the Shares or the accuracy, completeness or adequacy of
any information supplied to the Investor by or on behalf of the Issuer.

 

    6 

     

    

 

r.            The
Investor has or has commitments to have and, when required to deliver payment to the Issuer pursuant to Section 2 above,
will have, sufficient funds to pay the Subscription Amount and consummate the sale, purchase and issuance of the Shares pursuant to this
Subscription Agreement.

 

s.            The
Investor does not have, as of the date hereof, and during the 30-day period immediately prior to the date hereof such Investor has not
entered into, any “put equivalent position” as such term is defined in Rule 16a-1 under the Exchange Act or short sale
positions with respect to the securities of BOA. Notwithstanding the foregoing, in the case of an Investor that is a multi-managed investment
vehicle whereby separate portfolio managers manage separate portions of such Investor’s assets and the portfolio managers have
no direct knowledge of the investment decisions made by the portfolio managers managing other portions of such Investor’s assets,
the representation set forth above shall only apply with respect to the portion of assets managed by the portfolio manager that made
the investment decision to purchase the Shares covered by this Subscription Agreement.

 

t.            The
Investor is not a “foreign person” or a “foreign entity,” as defined in Section 721 of the Defense Production
Act of 1950, as amended, including, without limitation, all implementing regulations thereof (the “DPA”). The Investor
is not controlled by a “foreign person,” as defined in the DPA. The Investor does not permit any foreign person affiliated
with the Investor, whether affiliated as a limited partner or otherwise, to obtain through the Investor any of the following with respect
to the Issuer or BOA: (i) access to any “material nonpublic technical information” (as defined in the DPA) in the possession
of the Issuer or BOA; (ii) membership or observer rights on the board of directors or equivalent governing body of the Issuer or
BOA or the right to nominate an individual to a position on the board of directors or equivalent governing body of the Issuer or BOA;
(iii) any involvement, other than through the voting of shares, in the substantive decision-making of the Issuer or BOA regarding
(x) the use, development, acquisition, or release of any “critical technology” (as defined in the DPA), (y) the
use, development, acquisition, safekeeping, or release of “sensitive personal data” (as defined in the DPA) of U.S. citizens
maintained or collected by the Issuer or BOA, or (z) the management, operation, manufacture, or supply of “covered investment
critical infrastructure” (as defined in the DPA); or (iv) “control” (as defined in the DPA) of the Issuer or BOA.

 

u.           The
Investor has no binding arrangement in place to sell, transfer or otherwise dispose of any of the Shares subscribed for hereunder.

 

7.            Registration
Rights. The Issuer agrees that, within forty-five (45) calendar days after the consummation of the Transaction, it will file with
the SEC (at its sole cost and expense) a registration statement registering the resale of the Shares (the “Registration Statement”),
and it shall use its commercially reasonable efforts to have the Registration Statement declared effective as soon as practicable after
the filing thereof. The Issuer agrees to cause such Registration Statement, or another shelf registration statement that includes the
Shares to be sold pursuant to this Subscription Agreement, to remain effective until the earliest of (i) the second (2nd)
anniversary of the Closing, (ii) the date on which the Investor ceases to hold any Shares issued pursuant to this Subscription Agreement,
or (iii) on the first date on which the Investor is able to sell all of its Shares issued pursuant to this Subscription Agreement
under Rule 144 of the Securities Act without limitation, including as to the manner of sale or the amount of such securities that
may be sold and without the requirement for the Issuer to be in compliance with the current public information required under Rule 144(c)(1) (or
Rule 144(i)(2), if applicable). The Investor agrees to disclose its ownership to the Issuer upon request to assist it in making
the determination described above. The Investor acknowledges and agrees that the Issuer may suspend the use of any such registration
statement if it reasonably determines, upon the advice of legal counsel, that the registration statement would fail to comply with applicable
disclosure requirements. The Issuer’s obligations to include the Shares issued pursuant to this Subscription Agreement for resale
in the Registration Statement are contingent upon the Investor furnishing in writing to the Issuer such information regarding the Investor,
the securities of the Issuer held by the Investor, the intended method of disposition of such Shares, which shall be limited to non-underwritten
public offerings, and such other information as shall be reasonably requested by the Issuer to effect the registration of such Shares,
and shall execute such documents in connection with such registration as the Issuer may reasonably request that are customary of a selling
stockholder in similar situations.

 

    7 

     

    

 

8.            Termination.
This Subscription Agreement shall terminate and be void and of no further force and effect, and all rights and obligations of the parties
hereunder shall terminate without any further liability on the part of any party in respect thereof, upon the earliest to occur of (a) such
date and time as the Transaction Agreement is terminated in accordance with its terms, (b) the mutual written agreement of each
of the Investor and the Issuer (with the prior written consent of BOA) to terminate this Subscription Agreement, and (c) the delivery
of a notice of termination of this Subscription Agreement by either (i) the Investor to the Issuer or (ii) the Issuer to the
Investor following, in each case, the date that is thirty (30) calendar days after the Termination Date (as defined in the Transaction
Agreement, and such thirtieth calendar day, the “Outside Date”), if the Closing has not occurred by the Outside Date
(provided, that the right to terminate this Subscription Agreement pursuant to this clause (c) shall not be available to the Investor
if the Investor’s breach of any of its covenants or obligations under this Subscription Agreement (or if an affiliate of the Investor
is one of the PIPE Investors under an Other Subscription Agreement, and such Other Investor’s breach of any of its covenants or
obligations under the Other Subscription Agreement), either individually or in the aggregate, shall have proximately caused the failure
of the consummation of the Transaction on or before the Outside Date) (the termination events described in clauses (a)–(c) above,
collectively, the “Termination Events”); provided that nothing herein will relieve any party from liability
for any willful and material breach of any covenant, agreement, obligation, representation or warranty hereunder prior to the time of
termination, and each party will be entitled to any remedies at law or in equity to recover losses, liabilities or damages arising from
any such willful and material breach. The Issuer shall notify the Investor of the termination of the Transaction Agreement as promptly
as practicable after the termination of the Transaction Agreement. Upon the occurrence of any Termination Event, any monies paid by the
Investor to or on behalf of the Issuer in connection herewith shall promptly (and in any event within one business day) following the
Termination Event be returned to the Investor.

 

9.            Miscellaneous.

 

a.           Neither
this Subscription Agreement nor any rights that may accrue to the Investor hereunder (other than the Shares acquired hereunder, if any)
may be transferred or assigned.

 

b.            The
Issuer may request from the Investor such additional information as the Issuer may deem necessary or advisable to register the resale
of the Shares and evaluate the eligibility of the Investor to acquire the Shares, and the Investor shall promptly provide any such information
so requested. Without limiting the generality of the foregoing or any other covenants or agreements in this Subscription Agreement, the
Investor acknowledges that the Issuer may file a copy of this Subscription Agreement with the SEC as an exhibit to a current or periodic
report, or a registration statement of the Issuer.

 

c.          The
Investor acknowledges that the Issuer, BOA, the Placement Agents and others will rely on the acknowledgments, understandings, agreements,
representations and warranties contained in this Subscription Agreement. Prior to the Closing, the Investor agrees to promptly notify
the Issuer, BOA and the Placement Agents if any of the acknowledgments, understandings, agreements, representations or warranties set
forth in Section 6 above are no longer accurate. The Investor acknowledges and agrees that each purchase by the Investor
of Shares from the Issuer will constitute a reaffirmation of the acknowledgments, understandings, agreements, representations and warranties
herein by the Investor as of the time of such purchase.

 

d.            The
Investor acknowledges and agrees that neither it, nor any person or entity acting on its behalf or pursuant to any understanding with
the Investor, shall, directly or indirectly, engage in any hedging activities or execute any Short Sales with respect to any Shares or
any securities of BOA or any instrument exchangeable for or convertible into any Shares or any securities of BOA prior to the Closing
or the earlier termination of this Subscription Agreement in accordance with its terms. “Short Sales” shall include,
without limitation, all “short sales” as defined in Rule 200 of Regulation SHO under the Exchange Act and all types
of direct and indirect stock pledges (other than pledges in the ordinary course of business as part of prime brokerage arrangements),
forward sale contracts, options, puts, calls, swaps and similar arrangements (including, without limitation, on a total return basis),
and sales and other transactions through non-U.S. broker dealers or foreign regulated brokers.

 

e.           The
Issuer, BOA, and the Placement Agents are each entitled to rely upon this Subscription Agreement and each is irrevocably authorized to
produce this Subscription Agreement or a copy hereof to any interested party in any administrative or legal proceeding or official inquiry
with respect to the matters covered hereby; provided, however, that the foregoing clause of this Section 9(e) shall
not give the Issuer, BOA or the Placement Agents any rights other than those expressly set forth herein.

 

f.            All
of the agreements, representations and warranties made by each party hereto in this Subscription Agreement shall survive the Closing.

 

    8 

     

    

 

g.           This
Subscription Agreement may not be terminated other than pursuant to the terms of Section 8 above. The provisions of this
Subscription Agreement may not be modified, amended or waived except by an instrument in writing, signed by each of the parties hereto;
provided, however, that no modification, amendment or waiver by the Issuer of the provisions of this Subscription Agreement
shall be effective without the prior written consent of BOA (other than modifications, amendments or waivers that are solely ministerial
in nature or otherwise immaterial and, in each case, do not affect any economic or any other material term of this Subscription Agreement).
No failure or delay of either party in exercising any right or remedy hereunder shall operate as a waiver thereof, nor shall any single
or partial exercise of any such right or power, or any abandonment or discontinuance of steps to enforce such right or power, or any
course of conduct, preclude any other or further exercise thereof or the exercise of any other right or power. The rights and remedies
of the parties hereunder are cumulative and are not exclusive of any rights or remedies that they would otherwise have hereunder. For
the avoidance of doubt, the Investor acknowledges and agrees that the Issuer and BOA may amend the Transaction Agreement without the
consent of the Investor.

 

h.            This
Subscription Agreement (including, without limitation, the schedule hereto) constitutes the entire agreement, and supersedes all other
prior agreements, understandings, representations and warranties, both written and oral, among the parties, with respect to the subject
matter hereof. Except as set forth in Section 3(b), Section 8, Section 9(c), Section 9(e),
Section 9(g), this Section 9(h) and the last sentence of Section 9(l) with respect to the
persons specifically referenced therein, this Subscription Agreement shall not confer any rights or remedies upon any person other than
the parties hereto, and their respective successor and assigns, and the parties hereto acknowledge that such persons so referenced are
third party beneficiaries of this Subscription Agreement for the purposes of, and to the extent of, the rights granted to them, if any,
pursuant to the applicable provisions.

 

i.           Except
as otherwise provided herein, this Subscription Agreement shall be binding upon, and inure to the benefit of the parties hereto and their
heirs, executors, administrators, successors, legal representatives, and permitted assigns, and the agreements, representations, warranties,
covenants and acknowledgments contained herein shall be deemed to be made by, and be binding upon, such heirs, executors, administrators,
successors, legal representatives and permitted assigns.

 

j.           If
any provision of this Subscription Agreement shall be adjudicated by a court of competent jurisdiction to be invalid, illegal or unenforceable,
the validity, legality or enforceability of the remaining provisions of this Subscription Agreement shall not in any way be affected
or impaired thereby and shall continue in full force and effect.

 

k.            This
Subscription Agreement may be executed in one or more counterparts (including, without limitation, by facsimile or electronic mail or
in .pdf) and by different parties in separate counterparts, with the same effect as if all parties hereto had signed the same document.
All counterparts so executed and delivered shall be construed together and shall constitute one and the same agreement.

 

l.          The
parties hereto acknowledge and agree that irreparable damage would occur if any of the provisions of this Subscription Agreement were
not performed in accordance with their specific terms or were otherwise breached. It is accordingly agreed that the parties shall be
entitled to an injunction or injunctions to prevent breaches of this Subscription Agreement, without posting a bond or undertaking and
without proof of damages, to enforce specifically the terms and provisions of this Subscription Agreement, this being in addition to
any other remedy to which such party is entitled at law, in equity, in contract, in tort or otherwise. The parties hereto acknowledge
and agree that BOA shall be entitled to seek to specifically enforce the Investor’s obligations to fund the Subscription Amount,
the Issuer’s obligations under this Subscription Agreement and the provisions of the Subscription Agreement of which BOA is an
express third party beneficiary, in each case, on the terms and subject to the conditions set forth herein.

 

m.           Any
notice or communication required or permitted hereunder to be given to the Investor shall be in writing and either delivered personally,
emailed or sent by overnight mail via a reputable overnight carrier, or sent by certified or registered mail, postage prepaid, to such
address(es) or email address(es) set forth on the signature page hereto, and shall be deemed to be given and received (i) when
so delivered personally, (ii) when sent, with no mail undeliverable or other rejection notice, if sent by email, or (iii) three
(3) business days after the date of mailing to the address below or to such other address or addresses as the Investor may hereafter
designate by notice to the Issuer.

 

    9 

     

    

 

n.            THIS
SUBSCRIPTION AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF DELAWARE (REGARDLESS OF THE LAWS
THAT MIGHT OTHERWISE GOVERN UNDER APPLICABLE PRINCIPLES OF CONFLICTS OF LAWS THEREOF) AS TO ALL MATTERS (INCLUDING ANY ACTION, SUIT,
LITIGATION, ARBITRATION, MEDIATION, CLAIM, CHARGE, COMPLAINT, INQUIRY, PROCEEDING, HEARING, AUDIT, INVESTIGATION OR REVIEWS
BY OR BEFORE ANY GOVERNMENTAL ENTITY RELATED HERETO), INCLUDING MATTERS OF VALIDITY, CONSTRUCTION, EFFECT, PERFORMANCE AND REMEDIES.
THE PARTIES HERETO IRREVOCABLY SUBMIT TO THE EXCLUSIVE JURISDICTION OF THE CHANCERY COURT OF THE STATE OF DELAWARE (OR, IF THE CHANCERY
COURT OF THE STATE OF DELAWARE DECLINES TO ACCEPT JURISDICTION, THE SUPERIOR COURT OF THE STATE OF DELAWARE, OR THE UNITED STATES DISTRICT
COURT FOR THE DISTRICT OF DELAWARE) SOLELY IN RESPECT OF THE INTERPRETATION AND ENFORCEMENT OF THE PROVISIONS OF THIS SUBSCRIPTION AGREEMENT
AND THE DOCUMENTS REFERRED TO IN THIS SUBSCRIPTION AGREEMENT AND IN RESPECT OF THE TRANSACTIONS CONTEMPLATED HEREBY, AND HEREBY WAIVE,
AND AGREE NOT TO ASSERT, AS A DEFENSE IN ANY ACTION, SUIT OR PROCEEDING FOR INTERPRETATION OR ENFORCEMENT HEREOF OR ANY SUCH DOCUMENT
THAT IS NOT SUBJECT THERETO OR THAT SUCH ACTION, SUIT OR PROCEEDING MAY NOT BE BROUGHT OR IS NOT MAINTAINABLE IN SAID COURTS OR
THAT VENUE THEREOF MAY NOT BE APPROPRIATE OR THAT THIS SUBSCRIPTION AGREEMENT OR ANY SUCH DOCUMENT MAY NOT BE ENFORCED IN OR
BY SUCH COURTS, AND THE PARTIES HERETO IRREVOCABLY AGREE THAT ALL CLAIMS WITH RESPECT TO SUCH ACTION, SUIT OR PROCEEDING SHALL BE HEARD
AND DETERMINED BY SUCH COURT. THE PARTIES HEREBY CONSENT TO AND GRANT ANY SUCH COURT JURISDICTION OVER THE PERSON OF SUCH PARTIES AND
OVER THE SUBJECT MATTER OF SUCH DISPUTE AND AGREE THAT MAILING OF PROCESS OR OTHER PAPERS IN CONNECTION WITH SUCH ACTION, SUIT OR PROCEEDING
IN THE MANNER PROVIDED IN THIS SECTION 9(n) OF THIS SUBSCRIPTION AGREEMENT OR IN SUCH OTHER MANNER AS MAY BE PERMITTED
BY LAW SHALL BE VALID AND SUFFICIENT SERVICE THEREOF.

 

EACH PARTY ACKNOWLEDGES AND AGREES THAT ANY CONTROVERSY
WHICH MAY ARISE UNDER THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS CONTEMPLATED HEREBY IS LIKELY TO INVOLVE COMPLICATED AND DIFFICULT
ISSUES, AND THEREFORE EACH SUCH PARTY HEREBY IRREVOCABLY AND UNCONDITIONALLY WAIVES ANY RIGHT SUCH PARTY MAY HAVE TO A TRIAL BY
JURY IN RESPECT OF ANY LITIGATION DIRECTLY OR INDIRECTLY ARISING OUT OF OR RELATING TO THIS SUBSCRIPTION AGREEMENT OR THE TRANSACTIONS
CONTEMPLATED BY THIS SUBSCRIPTION AGREEMENT. EACH PARTY CERTIFIES AND ACKNOWLEDGES THAT (I) NO REPRESENTATIVE, AGENT OR ATTORNEY
OF ANY OTHER PARTY HAS REPRESENTED, EXPRESSLY OR OTHERWISE, THAT SUCH OTHER PARTY WOULD NOT, IN THE EVENT OF LITIGATION, SEEK TO
ENFORCE THE FOREGOING WAIVER; (II) SUCH PARTY UNDERSTANDS AND HAS CONSIDERED THE IMPLICATIONS OF THE FOREGOING WAIVER; (III) SUCH
PARTY MAKES THE FOREGOING WAIVER VOLUNTARILY AND (IV) SUCH PARTY HAS BEEN INDUCED TO ENTER INTO THIS SUBSCRIPTION AGREEMENT BY,
AMONG OTHER THINGS, THE MUTUAL WAIVER AND CERTIFICATIONS IN THIS SECTION 9(n).

 

    10 

     

    

 

10.            Non-Reliance
and Exculpation. The Investor acknowledges that it is not relying upon, and has not relied upon, any statement, representation
or warranty made by any person, firm or corporation (including, without limitation, the Issuer, BOA or the Placement Agents, any of their
respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives of any of the foregoing),
other than the statements, representations and warranties of the Issuer expressly contained in Section 5 of this Subscription
Agreement, in making its investment or decision to invest in the Issuer. The Investor acknowledges and agrees that none of (i) any
Other Investor pursuant to this Subscription Agreement or any Other Subscription Agreement related to the private placement of the Shares
(including the Investor’s respective affiliates or any control persons, officers, directors, employees, partners, agents or representatives
of any of the foregoing), (ii) the Placement Agents, their affiliates or any control persons, officers, directors, employees, partners,
agents or representatives of any of the foregoing, or (iii) any other party to the Transaction Agreement or any Non-Party Affiliate,
shall have any liability to the Investor, or to any Other Investor, pursuant to, arising out of or relating to this Subscription Agreement
or any Other Subscription Agreement related to the private placement of the Shares, the negotiation hereof or thereof or its subject
matter, or the transactions contemplated hereby or thereby, including, without limitation, with respect to any action heretofore or hereafter
taken or omitted to be taken by any of them in connection with the purchase of the Shares or with respect to any claim (whether in tort,
contract or otherwise) for breach of this Subscription Agreement or in respect of any written or oral representations made or alleged
to be made in connection herewith, as expressly provided herein, or for any actual or alleged inaccuracies, misstatements or omissions
with respect to any information or materials of any kind furnished by the Issuer, BOA, the Placement Agents or any Non-Party Affiliate
concerning the Issuer, BOA, the Placement Agents, any of their controlled affiliates, this Subscription Agreement or the transactions
contemplated hereby. For purposes of this Subscription Agreement, “Non-Party Affiliates” means each former, current or future
officer, director, employee, partner, member, manager, direct or indirect equityholder or affiliate of the Issuer, BOA, the Placement
Agents or any of the Issuer’s, the BOA’s or the Placement Agent’s controlled affiliates or any family member of the
foregoing.

 

11.            Trust
Account Waiver. The Investor acknowledges that BOA is a blank check company with the powers and privileges to effect a merger, asset
acquisition, reorganization or similar business combination involving BOA and one or more businesses or assets. The Investor further
acknowledges that, as described in BOA’s prospectus relating to its initial public offering dated February 24, 2021 (the “Prospectus”)
available at www.sec.gov, substantially all of BOA’s assets consist of the cash proceeds of BOA’s initial public offering
and private placement of its securities, and substantially all of those proceeds have been deposited in a trust account (the “Trust
Account”) for the benefit of BOA, its public shareholders and the underwriters of BOA’s initial public offering. Except
with respect to interest earned on the funds held in the Trust Account that may be released to BOA to pay its tax obligations, if any,
the cash in the Trust Account may be disbursed only for the purposes set forth in the Prospectus. Accordingly, the Investor (on behalf
of itself and its affiliates) hereby irrevocably waives any and all right, title and interest, or any claim of any kind it has or may
have in the future, in or to any monies held in the Trust Account, and agrees not to seek recourse against the Trust Account as a result
of, or arising out of, this Subscription Agreement or the transactions contemplated hereby regardless of whether such claim arises based
on contract, tort, equity or any other theory of legal liability; provided, however, that nothing in this Section 11
shall be deemed to limit the Investor’s right, title, interest or claim to any monies held in the Trust Account by virtue of
its record or beneficial ownership of any shares of Class A common stock, par value $0.0001 per share, of BOA currently outstanding
on the date hereof, pursuant to a validly exercised redemption right with respect to any such shares of Class A common stock, in
accordance with BOA’s Amended and Restated Certificate of Incorporation and the Investment Management Trust Agreement between Continental
Stock Transfer & Trust Company and BOA, dated February 23, 2021, except to the extent that the Investor has otherwise agreed
with BOA, the Issuer or any of their respective affiliates to not exercise such redemption right.

 

12.          Disclosure.
BOA shall, by 9:00 a.m., New York City time, on the first (1st) business day immediately following the date of this Subscription Agreement,
issue one or more press releases or file with the SEC a Current Report on Form 8-K (collectively, the “Disclosure Document”)
disclosing all material terms of the transactions contemplated hereby and by the Other Subscription Agreements and the Transaction. Upon
the issuance of the Disclosure Document, to the actual knowledge of BOA, the Investor shall not be in possession of any material, non-public
information received from BOA or any of its officers, directors, or employees or agents, and the Investor shall no longer be subject
to any confidentiality or similar obligations under any current agreement, whether written or oral with BOA or any of its affiliates,
relating to the transactions contemplated by this Subscription Agreement.

 

[SIGNATURE PAGES FOLLOW]

 

    11 

     

    

 

IN
WITNESS WHEREOF, the Investor has executed or caused this Subscription Agreement to be executed by its duly authorized representative
as of the date set forth below.

 

	Name of Investor:	State/Country of Formation or Domicile:
	 	 
	 	 
	By:	 	 
	Name:	 	 
	Title:	 	 
	 	 
	 	 
	Name in which Shares are to be registered (if different):	Date: ___________________, 2021
	 	 
	 	 
	Investor’s EIN:	 
	 	 
	 	 
	Business Address-Street:	Mailing Address-Street (if different):
	 	 
	 	 
	City, State, Zip:	City, State, Zip:
	 	 
	 	 
	Attn:	 	Attn:	 
	 	 
	 	 
	Telephone No.:	Telephone No.:
	Facsimile No.:	Facsimile No.:
	 	 
	 	 
	Number of Shares subscribed for:	 
	 	 
	 	 
	Aggregate Subscription Amount: $	Price Per Share: $10.00
	 	 

 

You must pay the Subscription
Amount by wire transfer of United States dollars in immediately available funds to the account specified by the Issuer in the Closing
Notice. To the extent the offering is oversubscribed, the number of Shares received may be less than the number of Shares subscribed
for.

 

     

     

    

 

IN WITNESS WHEREOF, the Issuer
has accepted this Subscription Agreement as of the date set forth below.

 

	 	SELINA HOLDING COMPANY, UK SOCIETAS
	 	 
	 	 
	 	By:	 
	 	Name:
	 	Title:
	Date:                     ,
    2021	

 

 

     

     

    

 

SCHEDULE A

 

ELIGIBILITY
REPRESENTATIONS OF THE INVESTOR

 

	A.	QUALIFIED INSTITUTIONAL BUYER STATUS

	 	(Please check the applicable subparagraphs):

 

		 ̈	We are a “qualified institutional
buyer” (as defined in Rule 144A under the Securities Act (a “QIB”)).

 

	B.	INSTITUTIONAL ACCREDITED INVESTOR STATUS

	 	(Please check the applicable subparagraphs):

 

	 	1.	 ̈  We
    are an “accredited investor” (within the meaning of Rule 501(a) under the Securities Act or an entity in which
    all of the equity holders are accredited investors within the meaning of Rule 501(a) under the Securities Act), and have
    marked and initialed the appropriate box on the following page indicating the provision under which we qualify as an “accredited
    investor.”

 

		2.	 ̈  We
are not a natural person.

 

Rule 501(a),
in relevant part, states that an “accredited investor” shall mean any person who comes within any of the below listed categories,
or who the issuer reasonably believes comes within any of the below listed categories, at the time of the sale of the securities to that
person. The Investor has indicated, by marking and initialing the appropriate box below, the provision(s) below which apply to the
Investor and under which the Investor accordingly qualifies as an “accredited investor.”

 

 ̈  Any
bank, registered broker or dealer, insurance company, registered investment company, business development company, or small business
investment company;

 

 ̈  Any
plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state or its political
subdivisions for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

 ̈  Any
employee benefit plan, within the meaning of the Employee Retirement Income Security Act of 1974, if a bank, insurance company, or registered
investment adviser makes the investment decisions, or if the plan has total assets in excess of $5,000,000;

 

 ̈  Any
organization described in Section 501(c)(3) of the Internal Revenue Code, corporation, similar business trust, or partnership,
not formed for the specific purpose of acquiring the securities offered, with total assets in excess of $5,000,000;

 

 ̈  Any
trust with assets in excess of $5,000,000, not formed to acquire the securities offered, whose purchase is directed by a sophisticated
person;

 

 ̈  Any
director, executive officer, or general partner of the issuer of the securities being offered or sold, or any director, executive officer,
or general partner of a general partner of that issuer;

 

 ̈  Any
natural person whose individual net worth, or joint net worth with that person’s spouse, exceeds $1,000,000. For purposes of calculating
a natural person’s net worth: (a) the person’s primary residence shall not be included as an asset; (b) indebtedness
that is secured by the person’s primary residence, up to the estimated fair market value of the primary residence at the time of
the sale of securities, shall not be included as a liability (except that if the amount of such indebtedness outstanding at the time
of sale of securities exceeds the amount outstanding sixty (60) days before such time, other than as a result of the acquisition of the
primary residence, the amount of such excess shall be included as a liability); and (c) indebtedness that is secured by the person’s
primary residence in excess of the estimated fair market value of the primary residence at the time of the sale of securities shall be
included as a liability;

 

     

     

    

 

 ̈  Any
natural person who had an individual income in excess of $200,000 in each of the two most recent years or joint income with that person’s
spouse in excess of $300,000 in each of those years and has a reasonable expectation of reaching the same income level in the current
year; or

 

 ̈  Any
entity in which all of the equity owners are accredited investors meeting one or more of the above tests.

 

This
page should be completed by the Investor

and
constitutes a part of the Subscription Agreement.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00337-of-00352.parquet"}]]